Abstract:
The present invention is directed to nucleic acid molecules and nucleic acid constructs, and other agents associated with fatty acid synthesis, particularly the ratios of saturated and unsaturated fats. Moreover, the present invention is directed to plants incorporating such agents where the plants exhibit altered ratios of saturated and unsaturated fats. In particular, the present invention is directed to plants incorporating such agents where the plants exhibit altered ratios of monounsaturated to polyunsaturated fatty acids.

Description:
CROSS-REFERENCE TO RELATED APPLICATIONS  
       [0001]    This application is a continuation-in-part of, and claims the benefit under 35 U.S.C. §120 of co-pending U.S. patent application Ser. No. 09/638,508, filed Aug. 11, 2000, which application claims priority to U.S. provisional application Ser. No. 60/151,224, filed Aug. 26, 1999 and U.S. provisional application Ser. No. 60/172,128, filed Dec. 17, 1999, all of which applications are herein incorporated by reference in their entireties. 
     
    
     
       INCORPORATION OF SEQUENCE LISTING  
         [0002]    A paper copy of the Sequence Listing and a computer readable form of the sequence listing on diskette, containing the file named Seq List 16518-056.txt, which is 43,401 bytes in size (measured in MS-DOS), and which was created on Mar. 20, 2002, are herein incorporated by reference.  
         FIELD OF THE INVENTION  
         [0003]    The present invention is directed to nucleic acid molecules and nucleic acid constructs, and other agents associated with fatty acid synthesis. Moreover, the present invention is directed to plants incorporating such agents where the plants exhibit altered ratios of saturated and unsaturated fats. In particular, the present invention is directed to plants incorporating such agents where the plants exhibit altered ratios of monounsaturated to polyunsaturated fatty acids.  
         BACKGROUND  
         [0004]    Plant oils are used in a variety of applications. Novel vegetable oils compositions and improved means to obtain oils compositions, from biosynthetic or natural plant sources, are needed. Depending upon the intended oil use, various different fatty acid compositions are desired.  
           [0005]    Higher plants appear to synthesize fatty acids via a common metabolic pathway—the fatty acid synthetase (FAS) pathway. In developing seeds, where fatty acids are attached to glycerol backbones, forming triglycerides, for storage as a source of energy for further germination, the FAS pathway is located in the plastids. The first committed step is the formation of acetyl-ACP (acyl carrier protein) from acetyl-CoA and ACP catalyzed by the enzyme, acetyl-CoA:ACP transacylase (ATA). Elongation of acetyl-ACP to 16- and 18-carbon fatty acids involves the cyclical action of the following sequence of reactions: condensation with a two-carbon unit from malonyl-ACP to form a β-ketoacyl-ACP (β-ketoacyl-ACP synthase), reduction of the keto-function to an alcohol (β-ketoacyl-ACP reductase), dehydration to form an enoyl-ACP (β-ketoacyl-ACP dehydratase), and finally reduction of the enoyl-ACP to form the elongated saturated acyl-ACP (enoyl-ACP reductase). β-ketoacyl-ACP synthase I catalyzes elongation up to palmitoyl-ACP (C16:0), whereas β-ketoacyl-ACP synthase II catalyzes the final elongation to stearoyl-ACP (C18:0). Common plant unsaturated fatty acids, such as oleic, linoleic and linolenic acids found in storage triglycerides, originate from the desaturation of stearoyl-ACP to form oleoyl-ACP (C 18:1) in a reaction catalyzed by a soluble plastid Δ-9 desaturase (also often referred to as “stearoyl-ACP desaturase”). Molecular oxygen is required for desaturation in which reduced ferredoxin serves as an electron co-donor. Additional desaturation is effected sequentially by the actions of membrane bound Δ-12 desaturase and Δ-15 desaturase. These “desaturases” thus create polyunsaturated fatty acids.  
           [0006]    Obtaining nucleic acid sequences capable of producing a phenotypic result in FAS, desaturation and/or incorporation of fatty acids into a glycerol backbone to produce an oil is subject to various obstacles including but not limited to the identification of metabolic factors of interest, choice and characterization of an enzyme source with useful kinetic properties, purification of the protein of interest to a level which will allow for its amino acid sequencing, utilizing amino acid sequence data to obtain a nucleic acid sequence capable to use as a probe to retrieve the desired DNA sequence, and the preparation of constructs, transformation and analysis of the resulting plants.  
           [0007]    Thus, additional nucleic acid targets and methods for modifying fatty acid compositions are needed. In particular, constructs and methods to produce a variety of ranges of different fatty acid compositions are needed.  
         SUMMARY OF THE INVENTION  
         [0008]    The present invention provides a substantially purified nucleic acid molecule comprising a nucleic acid sequence with at least 70% sequence identity to SEQ ID NO:12 or its complement. Also provided by the present invention is a substantially purified nucleic acid molecule comprising a nucleic acid sequence with at least 70% sequence identity to SEQ ID NO:13 or its complement.  
           [0009]    The present invention provides a substantially purified nucleic acid molecule comprising a nucleic acid sequence with at least 70% sequence identity to SEQ ID NO:14 or its complement. The present invention also provides a substantially purified nucleic acid molecule comprising a nucleic acid sequence with at least 70% sequence identity to SEQ ID NO:4 or its complement.  
           [0010]    Further provided by the present invention are a nucleic acid molecule comprising at least 15 consecutive nucleotides of a nucleic acid molecule having the sequence of SEQ ID NO:12; a nucleic acid molecule comprising at least 15 consecutive nucleotides of a nucleic acid molecule having the sequence of SEQ ID NO:13; a nucleic acid molecule comprising at least 15 consecutive nucleotides of a nucleic acid molecule having the sequence of SEQ ID NO:14; and a nucleic acid molecule comprising at least 15 consecutive nucleotides of a nucleic acid molecule having the sequence of SEQ ID NO:4.  
           [0011]    Also provided by the present invention is a recombinant nucleic acid molecule comprising as operably linked components: (A) a promoter that functions in a plant cell to cause production of an mRNA molecule; and (B) a nucleic acid sequence that hybridizes under high stringency conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:12 and complements thereof.  
           [0012]    Also provided by the present invention is a recombinant nucleic acid molecule comprising as operably linked components: (A) a promoter that functions in a plant cell to cause production of an mRNA molecule; and (B) a nucleic acid sequence that hybridizes under high stringency conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:13 and complements thereof.  
           [0013]    The present invention also provides a recombinant nucleic acid molecule comprising as operably linked components: (A) a promoter that functions in a plant cell to cause production of an mRNA molecule; and (B) a nucleic acid sequence that hybridizes under high stringency conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:14 and complements thereof.  
           [0014]    Also provided by the present invention is a recombinant nucleic acid molecule comprising as operably linked components: (A) a promoter that functions in a plant cell to cause production of an mRNA molecule; and (B) a nucleic acid sequence that hybridizes under high stringency conditions to a nucleic acid sequence selected from the group consisting of SEQ ID NO:4 and complements thereof.  
           [0015]    Further provided by the present invention is a transformed soybean plant having a nucleic acid molecule that comprises (a) a first promoter operably linked to a first nucleic acid molecule having a first nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, 2 and complements and fragments thereof, and (b) a second nucleic acid molecule having a second nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:4 through SEQ ID NO:14 and complements and fragments thereof, wherein the second nucleic acid molecule is operably linked to the first promoter or a second promoter.  
           [0016]    The present invention also provides a method of producing a soybean plant having a seed with reduced linolenic acid content comprising: transforming a soybean plant with a nucleic acid molecule that comprises (a) a first promoter operably linked to a first nucleic acid molecule having a first nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, 2 and complements thereof, and (b) a second nucleic acid molecule having a second nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:4 through SEQ ID NO:14 and complements thereof, wherein the second nucleic acid molecule is operably linked to the first promoter or a second promoter; and growing said plant, wherein said plant produces seed with less linolenic acid than a plant having a similar genetic background but lacking said nucleic acid molecule.  
           [0017]    The present invention also provides a method of producing a soybean plant having a seed with increased oleic acid content comprising: transforming a soybean plant with a nucleic acid molecule that comprises (a) a promoter operably linked to a first nucleic acid molecule having a first nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, 2 and complements thereof, and (b) a second nucleic acid molecule having a second nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:4 through SEQ ID NO:14 and complements thereof, wherein the second nucleic acid molecule is operably linked to the first promoter or a second promoter; and growing said plant, wherein said plant produces seed with more oleic acid than a plant having a similar genetic background but lacking said nucleic acid molecule.  
           [0018]    Also provided by the present invention is a transformed soybean plant having two or more nucleic acid molecules wherein each nucleic acid molecule is operably linked to a promoter and wherein each nucleic acid molecule has a nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1, 2, and 4-14 and complements and fragments thereof.  
           [0019]    The present invention provides a transformed soybean plant, wherein the level of a transcript encoded by a gene selected from the group consisting of FAD2-1A, FAD2-1B, FAD2-2B, FAD3-1A, FAD3-1B, FAD3-1C is selectively reduced while leaving the level of a transcript encoded by a different gene selected from the group consisting of FAD2-1A, FAD2-1B, FAD2-2B, FAD3-1A, FAD3-1B, FAD3-1C at least partially unaffected.  
           [0020]    The present invention also provides a method of producing a plant having a seed with a modified oil composition comprising: transforming a plant with a nucleic acid molecule that comprises, as operably linked components, a first promoter and a first nucleic acid molecule having a first nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, 2, 4 through 14 and complements thereof; and, growing said plant, wherein said plant produces seed with a modified oil composition compared to a plant having a similar genetic background but lacking said nucleic acid molecule.  
           [0021]    The present invention further provides a method of producing a plant having a seed with an altered ratio of monounsaturated to polyunsaturated fatty acids comprising: transforming a plant with a construct that comprises, as operably linked components, two or more nucleic acid molecules, each having a nucleic acid sequence that has 85% or greater identity to a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, 2, 4 through 14 and complements thereof, wherein each nucleic acid molecule is operably linked to a promoter; and, growing said plant, wherein said plant produces seed with an altered ratio of monounsaturated to polyunsaturated fatty acids compared to a plant having a similar genetic background but lacking said two or more nucleic acid molecules.  
         DETAILED DESCRIPTION OF THE INVENTION  
         [0022]    Description of the Nucleic Acid Sequences  
           [0023]    SEQ ID NO:1 sets forth a nucleic acid sequence of a FAD2-1A intron 1.  
           [0024]    SEQ ID NO:2 sets forth a nucleic acid sequence of a FAD2-1B intron 1.  
           [0025]    SEQ ID NO:3 sets forth a nucleic acid sequence of a partial FAD2-2 genomic clone.  
           [0026]    SEQ ID NO:4 sets forth a nucleic acid sequence of a FAD2-2B intron 1.  
           [0027]    SEQ ID NO:5 sets forth a nucleic acid sequence of a FAD3-1A intron 1.  
           [0028]    SEQ ID NO:6 sets forth a nucleic acid sequence of a FAD3-1A intron 2.  
           [0029]    SEQ ID NO:7 sets forth a nucleic acid sequence of a FAD3-1A intron 3A.  
           [0030]    SEQ ID NO:8 sets forth a nucleic acid sequence of a FAD3-1A intron 4  
           [0031]    SEQ ID NO:9 sets forth a nucleic acid sequence of a FAD3-1A intron 5.  
           [0032]    SEQ ID NO:10 sets forth a nucleic acid sequence of a FAD3-1A intron 3B.  
           [0033]    SEQ ID NO:11 sets forth a nucleic acid sequence of a FAD3-1A intron 3C.  
           [0034]    SEQ ID NO:12 sets forth a nucleic acid sequence of a FAD3-1B intron 3C.  
           [0035]    SEQ ID NO:13 sets forth a nucleic acid sequence of a FAD3-1B intron 4.  
           [0036]    SEQ ID NO:14 sets forth a nucleic acid sequence of a FAD3-1C intron 4.  
           [0037]    SEQ ID NO:15 sets forth a cDNA sequence of a FAD2-1A gene sequence.  
           [0038]    SEQ ID NOs:16 and 17 set forth nucleic acid sequences of FAD2-1A PCR primers.  
           [0039]    SEQ ID NO:18 sets forth a nucleic acid sequence of a partial FAD2-1A genomic clone.  
           [0040]    SEQ ID NO:19 sets forth a nucleic acid sequence of a partial FAD2-1B genomic clone.  
           [0041]    SEQ ID NOs:20 and 21 set forth nucleic acid sequences of FAD3-1A PCR primers.  
           [0042]    SEQ ID NO:22 sets forth a nucleic acid sequence of a FAD2-1B promoter.  
           [0043]    SEQ ID NO:23 sets forth a nucleic acid sequence of a partial FAD3-1A genomic clone.  
           [0044]    SEQ ID NOs:24 through 39 set forth nucleic acid sequences of PCR primers.  
           [0045]    Definitions  
           [0046]    As used herein, the term “gene” is used to refer to the nucleic acid sequence that encompasses the 5′ promoter region associated with the expression of the gene product, any intron and exon regions and 3′ untranslated regions associated with the expression of the gene product.  
           [0047]    As used herein, a “FAD2”, “Δ12 desaturase” or “omega-6 desaturase” gene is a gene that encodes an enzyme capable of catalyzing the insertion of a double bond into a fatty acyl moiety at the twelfth position counted from the carboxyl terminus.  
           [0048]    When referring to proteins and nucleic acids herein, the use of plain capitals, e.g., “FAD2”, indicates a reference to an enzyme, protein, polypeptide, or peptide, and the use of italicized capitals, e.g., “FAD2”, indicates a reference to nucleic acids, including without limitation genes, cDNAs, and mRNAs.  
           [0049]    As used herein the terminology “FAD2-1” is used to refer to a FAD2 gene that is naturally expressed in a specific manner in seed tissue.  
           [0050]    As used herein the terminology “FAD2-2” is used to refer a FAD2 gene that is (a) a different gene from a FAD2-1 gene and (b) is naturally expressed in multiple tissues, including the seed.  
           [0051]    As used herein, a “FAD3”, “Δ15 desaturase” or “omega-3 desaturase” gene is a gene that encodes an enzyme capable of catalyzing the insertion of a double bond into a fatty acyl moiety at the fifteenth position counted from the carboxyl terminus.  
           [0052]    As used herein the terminology “FAD3-1” is used to refer a FAD3 gene that is naturally expressed in multiple tissues, including the seed.  
           [0053]    As used herein the capital letter that follows the gene-terminology (A, B, C) is used to designate the family member, i.e. FAD2-1A is a different gene family member from FAD2-1B.  
           [0054]    As used herein, a “mid-oleic soybean seed” is a seed having between 50% and 75% oleic acid present in the oil composition of the seed.  
           [0055]    As used herein, a “high oleic soybean seed” is a seed with oil having greater than 75% oleic acid present in the oil composition of the seed.  
           [0056]    The term “non-coding” refers to sequences of nucleic acid molecules that do not encode part or all of an expressed protein. Non-coding sequences include but are not limited to introns, promoter regions, 3′ untranslated regions, and 5′ untranslated regions.  
           [0057]    The term “intron” as used herein refers to the normal sense of the term as meaning a segment of nucleic acid molecules, usually DNA, that does not encode part of or all of an expressed protein, and which, in endogenous conditions, is transcribed into RNA molecules, but which is spliced out of the endogenous RNA before the RNA is translated into a protein.  
           [0058]    The term “exon” as used herein refers to the normal sense of the term as meaning a segment of nucleic acid molecules, usually DNA, that encodes part of or all of an expressed protein.  
           [0059]    As used herein, a promoter that is “operably linked” to one or more nucleic acid sequences is capable of driving expression of one or more nucleic acid sequences, including multiple coding or non-coding nucleic acid sequences arranged in a polycistronic configuration.  
           [0060]    As used herein, the term complement of a nucleic acid sequence refers to the complement of the sequence along its complete length.  
           [0061]    As used herein, any range set forth is inclusive of the end points of the range unless otherwise stated.  
           [0062]    Agents  
           [0063]    The agents of the invention will preferably be “biologically active” with respect to either a structural attribute, such as the capacity of a nucleic acid molecule to hybridize to another nucleic acid molecule, or the ability of a protein to be bound by an antibody (or to compete with another molecule for such binding). Alternatively, such an attribute may be catalytic and thus involve the capacity of the agent to mediate a chemical reaction or response. The agents will preferably be “substantially purified.” The term “substantially purified,” as used herein, refers to a molecule separated from substantially all other molecules normally associated with it in its native environmental conditions. More preferably a substantially purified molecule is the predominant species present in a preparation. A substantially purified molecule may be greater than 60% free, greater than 75% free, preferably greater than 90% free, and most preferably greater than 95% free from the other molecules (exclusive of solvent) present in the natural mixture. The term “substantially purified” is not intended to encompass molecules present in their native environmental conditions.  
           [0064]    The agents of the invention may also be recombinant. As used herein, the term “recombinant” means any agent (e.g., including but limited to DNA, peptide), that is, or results, however indirectly, from human manipulation of a nucleic acid molecule.  
           [0065]    It is understood that the agents of the invention may be labeled with reagents that facilitate detection of the agent (e.g., fluorescent labels, Prober et al.,  Science  238:336-340 (1987); Albarella et al., EP 144914; chemical labels, Sheldon et al., U.S. Pat. No. 4,582,789; Albarella et al., U.S. Pat. No. 4,563,417; modified bases, Miyoshi et al., EP 119448).  
           [0066]    Nucleic Acid Molecules  
           [0067]    Agents of the invention include nucleic acid molecules. In an aspect of the present invention, the nucleic acid molecule comprises a nucleic acid sequence, which when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2 or FAD3 gene while leaving the level of a protein and/or transcript encoded by a second FAD2 or FAD3 gene partially unaffected. In a preferred aspect of the present invention, the nucleic acid molecule comprises a nucleic acid sequence, which when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2 or FAD3 gene while leaving the level of a protein and/or transcript encoded by a second FAD2 or FAD3 gene substantially unaffected. In a highly preferred aspect of the present invention, the nucleic acid molecule comprises a nucleic acid sequence, which when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2 or FAD3 gene while leaving the level of a protein and/or transcript encoded by a second FAD2 or FAD3 gene essentially unaffected.  
           [0068]    In a preferred aspect, the capability of a nucleic acid molecule to selectively reduce the level of a gene relative to another gene is carried out by a comparison of levels of mRNA transcripts. In another preferred aspect of the present invention, the nucleic acid molecule of the invention comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1 through 15, 18, 19, 22, 23 and complements thereof and fragments of either. In another preferred aspect of the present invention the nucleic acid molecule of the invention comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs:16, 17, 20, 21, 24 through 39, and complements thereof.  
           [0069]    In one aspect of the present invention the nucleic acids of the present invention are said to be introduced nucleic acid molecules. A nucleic acid molecule is said to be “introduced” if it is inserted into a cell or organism as a result of human manipulation, no matter how indirect. Examples of introduced nucleic acid molecules include, but are not limited to, nucleic acids that have been introduced into cells via transformation, transfection, injection, and projection, and those that have been introduced into an organism via methods including, but not limited to, conjugation, endocytosis, and phagocytosis. The cell or organism can be, or can be derived from, a plant, plant cell, algae cell, algae, fungal cell, fungus, or bacterial cell.  
           [0070]    As used herein, “essentially unaffected” refers to a level of an agent such as a protein or mRNA transcript that is either not altered by a particular event or altered only to an extent that does not affect the physiological function of that agent. In a preferred aspect, the level of the agent that is essentially unaffected is within 20%, more preferably within 10%, and even more preferably within 5% of the level at which it is found in a cell or organism that lacks a nucleic acid molecule capable of selectively reducing another agent.  
           [0071]    As used herein, “substantially unaffected” refers to a level of an agent such as a protein or mRNA transcript in which the level of the agent that is substantially unaffected is within 49%, more preferably within 35%, and even more preferably within 24% of the level at which it is found in a cell or organism that lacks a nucleic acid molecule capable of selectively reducing another agent.  
           [0072]    As used herein, “partially unaffected” refers to a level of an agent such as a protein or mRNA transcript in which the level of the agent that is partially unaffected is within 80%, more preferably within 65%, and even more preferably within 50% of the level at which it is found in a cell or organism that lacks a nucleic acid molecule capable of selectively reducing another agent.  
           [0073]    As used herein, “a selective reduction” of an agent such as a protein or mRNA is relative to a cell or organism lacking a nucleic acid molecule capable of selectively reducing the agent. In a preferred aspect, the level of the agent is selectively reduced by at least 50%, preferably at least more than 75%, and even more preferably by at least more than 90% or 95%.  
           [0074]    When levels of an agent are compared, such a comparison is preferably carried out between organisms with a similar genetic background. In a preferred aspect, a similar genetic background is a background where the organisms being compared share 50% or greater of their nuclear genetic material. In a more preferred aspect a similar genetic background is a background where the organisms being compared share 75% or greater, even more preferably 90% or greater of their nuclear genetic material. In another even more preferable aspect, a similar genetic background is a background where the organisms being compared are plants, and the plants are isogenic except for any genetic material originally introduced using plant transformation techniques.  
           [0075]    In an embodiment of the present invention, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2 gene while leaving the level of a protein and/or transcript encoded by a second FAD2 gene partially unaffected, substantially unaffected, or essentially unaffected. In a preferred aspect, the capability of a nucleic acid molecule to selectively reduce the level of a gene relative to another gene is carried out by a comparison of levels of mRNA transcripts. As used herein, mRNA transcripts include processed and non-processed mRNA transcripts.  
           [0076]    In another embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2-1 gene while leaving the level of a protein and/or transcript encoded by a FAD2-2 gene partially unaffected, substantially unaffected, or essentially unaffected. In a different embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2-2 gene while leaving the level of a protein and/or transcript encoded by a FAD2-1 gene partially unaffected, substantially unaffected, or essentially unaffected.  
           [0077]    In a further embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2 gene while leaving the level of a protein and/or transcript encoded by a FAD3 gene partially unaffected, substantially unaffected, or essentially unaffected. In a preferred embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2-1 gene while leaving the level of a protein and/or transcript encoded by a FAD3 gene partially unaffected, substantially unaffected, or essentially unaffected.  
           [0078]    In a different embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3 gene while leaving the level of a protein and/or transcript encoded by another FAD3 gene partially unaffected, substantially unaffected, or essentially unaffected.  
           [0079]    In an additional embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3-1C gene while leaving the level of a protein and/or transcript encoded by a FAD3-1B gene partially unaffected, substantially unaffected, or essentially unaffected. In an additional embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3-1C gene while leaving the level of a protein and/or transcript encoded by a FAD3-1A gene partially unaffected, substantially unaffected, or essentially unaffected.  
           [0080]    In a different embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3-1B gene while leaving the level of a protein and/or transcript encoded by a FAD3-1C gene partially unaffected, substantially unaffected, or essentially unaffected. In a different embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3-1B gene while leaving the level of a protein and/or transcript encoded by a FAD3-1A gene partially unaffected, substantially unaffected, or essentially unaffected.  
           [0081]    In a further embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3-1A gene while leaving the level of a protein and/or transcript encoded by a FAD3-1B gene partially unaffected, substantially unaffected, or essentially unaffected. In an additional embodiment, a nucleic acid molecule, when introduced into a cell or organism, is capable of selectively reducing the level of a protein and/or transcript encoded by a FAD3-1A gene while leaving the level of a protein and/or transcript encoded by a FAD3-1C gene partially unaffected, substantially unaffected, or essentially unaffected.  
           [0082]    Further preferred embodiments of the invention are nucleic acid molecules that are at least 50%, 60%, or 70% identical over their entire length to a nucleic acid molecule of the invention, and nucleic acid molecules that are complementary to such nucleic acid molecules. More preferable are nucleic acid molecules that comprise a region that is at least 80% or 85% identical over its entire length to a nucleic acid molecule of the invention and nucleic acid molecules that are complementary thereto. In this regard, nucleic acid molecules at least 90% identical over their entire length are particularly preferred, those at least 95% identical are especially preferred. Further, those with at least 97% identity are highly preferred and those with at least 98% and 99% identity are particularly highly preferred, with those at least 99% being the most highly preferred.  
           [0083]    The invention also provides a nucleic acid molecule comprising a nucleic acid molecule sequence obtainable by screening an appropriate library containing the complete gene for a nucleic acid molecule sequence set forth in the Sequence Listing under stringent hybridization conditions with a probe having the sequence of said nucleic acid molecule sequence or a fragment thereof; and isolating said nucleic acid molecule sequence. Fragments useful for obtaining such a nucleic acid molecule include, for example, probes and primers as described herein.  
           [0084]    Nucleic acid molecules of the invention can be used as a hybridization probe for RNA, cDNA, or genomic DNA to isolate full length cDNAs or genomic clones and to isolate cDNA or genomic clones of other genes that have a high sequence similarity to a nucleic acid molecule set forth in the Sequence Listing.  
           [0085]    The nucleic acid molecules of the present invention can be readily obtained by using the herein described nucleic acid molecules or fragments thereof to screen cDNA or genomic libraries obtained from plant species or other appropriate organisms. These methods are known to those of skill in the art, as are methods for forming such libraries. In one embodiment, such sequences are obtained by incubating nucleic acid molecules of the present invention with members of genomic libraries and recovering clones that hybridize to such nucleic acid molecules thereof. In a second embodiment, methods of chromosome walking or inverse PCR may be used to obtain such sequences. In a third embodiment, the sequence of a nucleic acid molecule of the present invention may be used to screen a library or database, using bioinformatics techniques known in the art. See, e.g.,  Bioinformatics,  Baxevanis &amp; Ouellette, eds., Wiley-Interscience (1998).  
           [0086]    Any of a variety of methods may be used to obtain one or more of the nucleic acid molecules of the present invention. Automated nucleic acid synthesizers may be employed for this purpose, and to make a nucleic acid molecule that has a sequence also found in a cell or organism. In lieu of such synthesis, the disclosed nucleic acid molecules may be used to define a pair of primers that can be used with the polymerase chain reaction to amplify and obtain any desired nucleic acid molecule or fragment.  
           [0087]    “Identity,” as is well understood in the art, is a relationship between two or more polypeptide sequences or two or more nucleic acid molecule sequences, as determined by comparing the sequences. In the art, “identity” also means the degree of sequence relatedness between polypeptide or nucleic acid molecule sequences, as determined by the match between strings of such sequences. “Identity” can be readily calculated by known methods including, but not limited to, those described in  Computational Molecular Biology,  Lesk, A. M., ed., Oxford University Press, New York (1988);  Biocomputing: Informatics and Genome Projects,  Smith, D. W., ed., Academic Press, New York, 1993;  Computer Analysis of Sequence Data, Part I,  Griffin, A. M. and Griffin, H. G., eds., Humana Press, New Jersey (1994);  Sequence Analysis in Molecular Biology,  von Heinje, G., Academic Press (1987);  Sequence Analysis Primer,  Gribskov, M. and Devereux, J., eds., Stockton Press, New York (1991); and Carillo, H., and Lipman, D., SIAM  J Applied Math,  48:1073 (1988). Methods to determine identity are designed to give the largest match between the sequences tested. Moreover, methods to determine identity are codified in publicly available programs. Computer programs which can be used to determine identity between two sequences include, but are not limited to, GCG (Devereux, J., et al.,  Nucleic Acids Research  12(1):387 (1984); suite of five BLAST programs, three designed for nucleotide sequences queries (BLASTN, BLASTX, and TBLASTX) and two designed for protein sequence queries (BLASTP and TBLASTN) (Coulson,  Trends in Biotechnology,  12:76-80 (1994); Birren et al.,  Genome Analysis,  1:543-559 (1997)). The BLASTX program is publicly available from NCBI and other sources ( BLAST Manual,  Altschul, S., et al., NCBI NLM NIH, Bethesda, Md. 20894; Altschul, S., et al.,  J. Mol. Biol.,  215:403-410 (1990)). The well-known Smith Waterman algorithm can also be used to determine identity.  
           [0088]    Parameters for polypeptide sequence comparison typically include the following:  
           [0089]    Algorithm: Needleman and Wunsch,  J. Mol. Biol.,  48:443-453 (1970)  
           [0090]    Comparison matrix: BLOSSUM62 from Hentikoff and Hentikoff,  Proc. Natl. Acad. Sci. USA,  89:10915-10919 (1992)  
           [0091]    Gap Penalty: 12  
           [0092]    Gap Length Penalty: 4  
           [0093]    A program which can be used with these parameters is publicly available as the “gap” program from Genetics Computer Group, Madison, Wis. The above parameters along with no penalty for end gap are the default parameters for peptide comparisons.  
           [0094]    Parameters for nucleic acid molecule sequence comparison include the following:  
           [0095]    Algorithm: Needleman and Wunsch,  J. Mol. Bio.,  48:443-453 (1970)  
           [0096]    Comparison matrix: matches—+10; mismatches=0  
           [0097]    Gap Penalty: 50  
           [0098]    Gap Length Penalty: 3  
           [0099]    As used herein, “% identity” is determined using the above parameters as the default parameters for nucleic acid molecule sequence comparisons and the “gap” program from GCG, version 10.2.  
           [0100]    The invention further relates to nucleic acid molecules that hybridize to nucleic acid molecules of the present invention. In particular, the invention relates to nucleic acid molecules that hybridize under stringent conditions to the above-described nucleic acid molecules. As used herein, the terms “stringent conditions” and “stringent hybridization conditions” mean that hybridization will generally occur if there is at least 95% and preferably at least 97% identity between the sequences. An example of stringent hybridization conditions is overnight incubation at 42° C. in a solution comprising 50% formamide, 5× SSC (150 mM NaCl, 15 mM trisodium citrate), 50 mM sodium phosphate (pH 7.6), 5× Denhardt&#39;s solution, 10% dextran sulfate, and 20 micrograms/milliliter denatured, sheared salmon sperm DNA, followed by washing the hybridization support in 0.1× SSC at approximately 65° C. Other hybridization and wash conditions are well known and are exemplified in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor, N.Y. (1989), particularly Chapter 11.  
           [0101]    In embodiments where nucleic acid sequences which when expressed are capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2-1 gene and the level of a protein and/or transcript encoded by at least one FAD3 gene while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant partially, substantially or essentially unaffected, preferred FAD2-1 nucleic acid sequences are selected from the groups consisting of (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2 and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence of SEQ ID NO:4; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD2-1 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2).  
           [0102]    In embodiments where nucleic acid sequences which when expressed are capable of selectively reducing the level of a protein and/or transcript encoded by a FAD2-2 gene and the level of a protein and/or transcript encoded by at least one FAD3 gene while leaving the level of a protein and/or transcript of a FAD2-1 gene in the plant partially, substantially or essentially unaffected, preferred FAD2-2 nucleic acid sequences are selected from the groups consisting of (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence of SEQ ID NO:4 and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO:1 and SEQ ID NO:2; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD2-2 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2).  
           [0103]    In embodiments where nucleic acid sequences which when expressed are capable of selectively reducing a FAD3 gene, preferred FAD3 nucleic acid sequences are selected from the groups consisting of (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NOs:5-14, and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:2, and SEQ ID NO:4; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD3 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2).  
           [0104]    One subset of the nucleic acid molecules of the invention includes fragment nucleic acid molecules. Fragment nucleic acid molecules may consist of significant portion(s) of, or indeed most of, the nucleic acid molecules of the invention, such as those specifically disclosed. Alternatively, the fragments may comprise smaller oligonucleotides (having from about 15 to about 400 contiguous nucleotide residues and more preferably, about 15 to about 30 contiguous nucleotide residues, or about 50 to about 100 contiguous nucleotide residues, or about 100 to about 200 contiguous nucleotide residues, or about 200 to about 400 contiguous nucleotide residues, or about 275 to about 350 contiguous nucleotide residues).  
           [0105]    In another aspect, a fragment nucleic acid molecule has a nucleic acid sequence that is at least 15, 25, 50, or 100 contiguous nucleotides of a nucleic acid molecule of the present invention. In a preferred embodiment, the nucleic acid molecule has a nucleic acid sequence that is at least 15, 25, 50, or 100 contiguous nucleotides of a nucleic acid molecule having a nucleic acid sequence selected from the group consisting of SEQ ID NO:1 through SEQ ID NO:14 and complements thereof.  
           [0106]    A fragment of one or more of the nucleic acid molecules of the present invention may be a probe and specifically a PCR probe. A PCR probe is a nucleic acid molecule capable of initiating a polymerase activity while in a double-stranded structure with another nucleic acid molecule. Various methods for determining the structure of PCR probes and PCR techniques exist in the art. Computer generated searches using programs such as Primer3 (www-genome.wi.mit.edu/cgi-bin/primer/primer3.cgi), STSPipeline (www-genome.wi.mit.edu/cgi-bin/www-STS_Pipeline), or GeneUp (Pesole et al.,  BioTechniques  25:112-123 (1998)), for example, can be used to identify potential PCR primers.  
           [0107]    Nucleic acid molecules or fragments thereof of the present invention are capable of specifically hybridizing to other nucleic acid molecules under certain circumstances. Nucleic acid molecules of the present invention include those that specifically hybridize to nucleic acid molecules having a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1-14, and complements thereof.  
           [0108]    As used herein, two nucleic acid molecules are said to be capable of specifically hybridizing to one another if the two molecules are capable of forming an anti-parallel, double-stranded nucleic acid structure.  
           [0109]    A nucleic acid molecule of the invention can also encode a homolog nucleic acid molecule. As used herein, a homolog nucleic acid molecule or fragment thereof is a counterpart nucleic acid molecule or fragment thereof in a second species (e.g., corn FAD2-1 intron nucleic acid molecule is a homolog of Arabidopsis FAD2-1 intron nucleic acid molecule). A homolog can also be generated by molecular evolution or DNA shuffling techniques, so that the molecule retains at least one functional or structure characteristic of the original polypeptide (see, for example, U.S. Pat. No. 5,811,238).  
           [0110]    In another embodiment, the homolog is obtained from a plant selected from the group consisting of alfalfa, Arabidopsis, barley,  Brassica campestris,  oilseed rape, broccoli, cabbage, canola, citrus, cotton, garlic, oat, Allium, flax, an ornamental plant, jojoba, corn, peanut, pepper, potato, rapeseed, rice, rye, sorghum, strawberry, sugarcane, sugarbeet, tomato, wheat, poplar, pine, fir, eucalyptus, apple, lettuce, lentils, grape, banana, tea, turf grasses, sunflower, Phaseolus, crambe, mustard, castor bean, sesame, cottonseed, linseed, safflower, and oil palm. More particularly, a preferred homolog is obtained from a plant selected from the group consisting of canola, corn,  Brassica campestris,  oilseed rape, soybean, crambe, mustard, castor bean, peanut, sesame, cottonseed, linseed, rapeseed, safflower, oil palm, flax, and sunflower. In an even more preferred embodiment, the homolog is obtained from a plant selected from the group consisting of canola, rapeseed, corn,  Brassica campestris,  oilseed rape, soybean, sunflower, safflower, oil palm, and peanut.  
           [0111]    Plant Constructs and Plant Transformants  
           [0112]    One or more of the nucleic acid molecules of the invention may be used in plant transformation or transfection. Exogenous genetic material may be transferred into a plant cell and the plant cell regenerated into a whole, fertile or sterile plant or plant part. Exogenous genetic material is any genetic material, whether naturally occurring or otherwise, from any source that is capable of being inserted into any organism.  
           [0113]    A plant can have a family of more than one FAD2 or FAD3 genes (i.e., genes which encode an enzyme with the specified activity present at different locations within the genome of the plants). As used herein, a “FAD2 gene family member” is any FAD2 gene found within the genetic material of the plant. As used herein, a “FAD3 gene family member” is any FAD3 gene found within the genetic material of the plant. In one embodiment, a gene family can be additionally classified by the similarity of the nucleic acid sequences. In a preferred aspect of this embodiment, a gene family member exhibits at least 60%, more preferably at least 70%, more preferably at least 80% nucleic acid sequence identity in the coding sequence portion of the gene.  
           [0114]    In one embodiment of the invention, the expression level of a protein or transcript in one family member of that gene is selectively reduced while leaving the level of a protein or transcript of a second family member partially unaffected. In a preferred embodiment of the invention, the expression level of a protein or transcript in one family member of that gene is selectively reduced while leaving the level of a protein or transcript of a second family member substantially unaffected. In a highly preferred embodiment of the invention, the expression level of a protein or transcript in one family member of that gene is selectively reduced while leaving the level of a protein or transcript of a second family member essentially unaffected.  
           [0115]    In a particularly preferred embodiment, a plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by certain FAD2 and FAD3 genes while leaving the level of a protein and/or transcript of at least one other FAD2 or FAD3 gene in the plant partially unaffected. In a particularly preferred embodiment, a plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by certain FAD2 and FAD3 genes while leaving the level of a protein and/or transcript of at least one other FAD2 or FAD3 gene in the plant substantially unaffected. In a particularly preferred embodiment, a plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by certain FAD2 and FAD3 genes while leaving the level of a protein and/or transcript of at least one other FAD2 or FAD3 gene in the plant essentially unaffected.  
           [0116]    In a more particularly preferred embodiment, a soybean plant of the present, invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least one FAD3 gene while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant partially unaffected. In a more particularly preferred embodiment, a soybean plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least one FAD3 gene while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant substantially unaffected. In a more particularly preferred embodiment, a soybean plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least one FAD3 gene while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant essentially unaffected.  
           [0117]    In another more particularly preferred embodiment, a soybean plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least two, three or more FAD3 genes while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant partially unaffected. In another more particularly preferred embodiment, a soybean plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least two, three or more FAD3 genes while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant substantially unaffected. In another more particularly preferred embodiment, a soybean plant of the present invention includes nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least two, three or more FAD3 genes while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant essentially unaffected.  
           [0118]    In a preferred embodiment, a soybean of the present invention includes exogenous nucleic acid sequences selected from the groups consisting of a FAD3 intron or fragment thereof, more preferably from a nucleic acid molecule selected from the group consisting of SEQ ID NOs:5-14, or fragments thereof.  
           [0119]    In a particularly preferred embodiment, a soybean of the present invention includes a nucleic acid sequence which when expressed is capable of reducing the expression level of a protein and/or transcript encoded by a FAD3-1C gene while leaving the level of a protein and/or transcript of a FAD3-1B gene in the plant partially unaffected. In a particularly preferred embodiment, a soybean of the present invention includes a nucleic acid sequence which when expressed is capable of reducing the expression level of a protein and/or transcript encoded by a FAD3-1C gene while leaving the level of a protein and/or transcript of a FAD3-1B gene in the plant substantially unaffected. In a particularly preferred embodiment, a soybean of the present invention includes a nucleic acid sequence which when expressed is capable of reducing the expression level of a protein and/or transcript encoded by a FAD3-1C gene while leaving the level of a protein and/or transcript of a FAD3-1B gene in the plant essentially unaffected.  
           [0120]    In embodiments where nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least one FAD3 genes while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant partially unaffected, substantially unaffected, or essentially unaffected, preferred FAD2-1 nucleic acid sequences are selected from the groups consisting of (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2 and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence of SEQ ID NO:4; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD2-1 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2).  
           [0121]    In embodiments where nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD3 gene, preferred FAD3 nucleic acid sequences are selected from the groups consisting of (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NOs:5-14, and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:4; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD3 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2).  
           [0122]    In a preferred embodiment, a soybean seed of the present invention has an oil composition that is 50% or greater oleic acid and 10% or less linolenic acid. In a more preferred embodiment, a soybean seed of the present invention has an oil composition that is 60% or greater oleic acid and 7% or less linolenic acid. In a particular preferred embodiment, a soybean seed of the present invention has an oil composition that is 65% or greater oleic acid and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid. As used herein, all % composition of oils within a plant or plant part such as a seed are determined by relative mole percent.  
           [0123]    In another preferred embodiment a soybean seed of the present invention has an oil composition that is between 50% and 90% oleic acid, and 10% or less linolenic acid. In a more preferred embodiment, a soybean seed of the present invention has an oil composition that is between 60% and 80% oleic acid, and 7% or less linolenic acid. In a particular preferred embodiment, a soybean seed of the present invention has an oil composition that is between 65% and 75% oleic acid, and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid.  
           [0124]    In a particularly preferred embodiment, a soybean seed of the present invention has an oil composition that is between 65% and 75% oleic acid, and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid, where nucleic acid sequences which when expressed are capable of selectively reducing the expression level of a protein and/or transcript encoded by a FAD2-1 gene and at least one FAD3 gene while leaving the level of a protein and/or transcript of a FAD2-2 gene in the plant partially unaffected, substantially unaffected, or essentially unaffected, the FAD2-1 nucleic acid sequences are selected from the groups consisting of: (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2 and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence of SEQ ID NO:4; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD2-1 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2); and the FAD3 nucleic acid sequences are selected from the groups consisting of (1) nucleic acid sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NOs:5-14, and fragments thereof, where such a nucleic acid sequence does not hybridize under stringent conditions to a nucleic acid molecule with a nucleotide sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:4; (2) nucleic acid molecules which contain sequences that are also found in a soybean FAD3 gene intron; and (3) nucleic acid molecules that exhibit sequences with at least 50%, 60%, 70%, 80%, 90%, 95%, 97%, 98%, 99% or 100% sequence identity over the entire length of the nucleic acid molecule with a nucleic acid molecule of (2).  
           [0125]    In another embodiment, a soybean seed of the present invention has an oil composition that is 80% or greater, more preferably 90% or greater oleic acid and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid.  
           [0126]    In a preferred embodiment, a soybean seed of the present invention has an oil composition that is 80% or greater, more preferably 90% or greater oleic acid and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid, where the nucleic acid sequences are capable of reducing the expression of FAD2-1, FAD2-2 and at least one FAD3 genes. In a particularly preferred embodiment of this aspect, the nucleic acid sequences are selected from the group consisting of SEQ ID NO:1 through SEQ ID NO:14 and complements thereof.  
           [0127]    In a preferred embodiment of the present invention, a soybean seed of the present invention has an oil composition of 50% or greater oleic acid, more preferably 60% or greater, 70% or greater, 80% or greater, or 90% or greater oleic acid.  
           [0128]    In another preferred embodiment of the present invention, a soybean seed of the present invention has an oil composition that is 10% or less linolenic acid, more preferably 5% or less, 4% or less, or 3% or less linolenic acid.  
           [0129]    Such genetic material may be transferred into either monocotyledons or dicotyledons including, but not limited to canola, corn, soybean, Arabidopsis, Phaseolus, peanut, alfalfa, wheat, rice, oat, sorghum, rapeseed, rye, barley, millet, fescue, perennial ryegrass, sugarcane, cranberry, papaya, banana, safflower, oil palm, flax, muskmelon, apple, cucumber, dendrobium, gladiolus, chrysanthemum, liliacea, cotton, eucalyptus, sunflower,  Brassica campestris,  oilseed rape, turfgrass, sugarbeet, coffee and dioscorea (Christou, INO: Particle Bombardment for Genetic Engineering of Plants,  Biotechnology Intelligence Unit. Academic Press, San Diego, Calif. (1996)), with canola, corn,  Brassica campestris,  oilseed rape, rapeseed, soybean, crambe, mustard, castor bean, peanut, sesame, cottonseed, linseed, safflower, oil palm, flax, and sunflower preferred, and canola, rapeseed, corn,  Brassica campestris,  oilseed rape, soybean, sunflower, safflower, oil palms, and peanut more preferred. In a more preferred embodiment, the genetic material is transferred into canola. In another more preferred embodiment, the genetic material is transferred into oilseed rape. In another particularly preferred embodiment, the genetic material is transferred into soybean.  
           [0130]    The levels of products such as transcripts or proteins may be increased or decreased throughout an organism such as a plant or localized in one or more specific organs or tissues of the organism. For example the levels of products may be increased or decreased in one or more of the tissues and organs of a plant including without limitation: roots, tubers, stems, leaves, stalks, fruit, berries, nuts, bark, pods, seeds and flowers. A preferred organ is a seed.  
           [0131]    Exogenous genetic material may be transferred into a host cell by the use of a DNA vector or construct designed for such a purpose. Design of such a vector is generally within the skill of the art (See,  Plant Molecular Biology: A Laboratory Manual,  Clark (ed.), Springer, N.Y. (1997)).  
           [0132]    A construct or vector may include a plant promoter to express the nucleic acid molecule of choice. In a preferred embodiment, any nucleic acid molecules described herein can be operably linked to a promoter region which functions in a plant cell to cause the production of an mRNA molecule. For example, any promoter that functions in a plant cell to cause the production of an mRNA molecule, such as those promoters described herein, without limitation, can be used. In a preferred embodiment, the promoter is a plant promoter.  
           [0133]    A number of promoters that are active in plant cells have been described in the literature. These include, but are not limited to, the nopaline synthase (NOS) promoter (Ebert et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 84:5745-5749 (1987)), the octopine synthase (OCS) promoter (which is carried on tumor-inducing plasmids of  Agrobacterium tumefaciens ), the caulimovirus promoters such as the cauliflower mosaic virus (CaMV) 19S promoter (Lawton et al.,  Plant Mol. Biol.  9:315-324 (1987)) and the CaMV 35S promoter (Odell et al.,  Nature  313:810-812 (1985)), the figwort mosaic virus 35S-promoter (U.S. Pat. No. 5,378,619), the light-inducible promoter from the small subunit of ribulose-1,5-bis-phosphate carboxylase (ssRUBISCO), the Adh promoter (Walker et al.,  Proc. Natl. Acad. Sci.  ( U.S.A ) 84:6624-6628 (1987)), the sucrose synthase promoter (Yang et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 87:4144-4148 (1990)), the R gene complex promoter (Chandler et al.,  The Plant Cell  1:1175-1183 (1989)) and the chlorophyll a/b binding protein gene promoter. These promoters have been used to create DNA constructs that have been expressed in plants; see, e.g., PCT publication WO 84/02913. The CaMV 35S promoters are preferred for use in plants. Promoters known or found to cause transcription of DNA in plant cells can be used in the invention.  
           [0134]    Particularly preferred promoters can also be used to express a nucleic acid molecule of the present invention in seeds or fruits. Indeed, in a preferred embodiment, the promoter used is a seed specific promoter. Examples of such promoters include the 5′ regulatory regions from such genes as napin (Kridl et al.,  Seed Sci. Res.  1:209:219 (1991)), phaseolin (Bustos, et al,  Plant Cell,  1(9):839-853 (1989)), soybean trypsin inhibitor (Riggs, et al.,  Plant Cell  1(6):609-621 (1989)), ACP (Baerson, et al.,  Plant Mol. Biol.,  22(2):255-267 (1993)), stearoyl-ACP desaturase (Slocombe, et al.,  Plant Physiol.  104(4):167-176 (1994)), soybean a′ subunit of b-conglycinin (soy 7s, (Chen et al.,  Proc. Natl. Acad. Sci.,  83:8560-8564 (1986))), and oleosin (see, for example, Hong, et al.,  Plant Mol. Biol.,  34(3):549-555 (1997)). Further examples include the promoter for β-conglycinin (Chen et al.,  Dev. Genet.  10:112-122 (1989)) and the promoter for FAE (PCT Publication WO 01/11061). Preferred promoters for expression in the seed are 7S and napin promoters.  
           [0135]    Also included are the zein promoters, which are a group of storage proteins found in corn endosperm. Genomic clones for zein genes have been isolated (Pedersen et al.,  Cell  29:1015-1026 (1982), and Russell et al.,  Transgenic Res.  6(2): 157-168) and the promoters from these clones, including the 15 kD, 16 kD, 19 kD, 22 kD, and 27 kD genes, could also be used. Other promoters known to function, for example, in corn include the promoters for the following genes: waxy, Brittle, Shrunken 2, Branching enzymes I and II, starch synthases, debranching enzymes, oleosins, glutelins and sucrose synthases. A particularly preferred promoter for corn endosperm expression is the promoter for the glutelin gene from rice, more particularly the Osgt-1 promoter (Zheng et al.,  Mol. Cell Biol.  13:5829-5842 (1993)). Examples of promoters suitable for expression in wheat include those promoters for the ADPglucose pyrosynthase (ADPGPP) subunits, the granule bound and other starch synthase, the branching and debranching enzymes, the embryogenesis-abundant proteins, the gliadins and the glutenins. Examples of such promoters in rice include those promoters for the ADPGPP subunits, the granule bound and other starch synthase, the branching enzymes, the debranching enzymes, sucrose synthases and the glutelins. A particularly preferred promoter is the promoter for rice glutelin, Osgt-1. Examples of such promoters for barley include those for the ADPGPP subunits, the granule bound and other starch synthase, the branching enzymes, the debranching enzymes, sucrose synthases, the hordeins, the embryo globulins and the aleurone specific proteins.  
           [0136]    Tissue-specific expression of a protein of the present invention is a particularly preferred embodiment. The tissue-specific promoters that can be used include the chloroplast glutamine synthetase GS2 promoter from pea (Edwards et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 87:3459-3463 (1990)), the chloroplast fructose-1,6-biphosphatase (FBPase) promoter from wheat (Lloyd et al.,  Mol. Gen. Genet.  225:209-216 (1991)), the nuclear photosynthetic ST-LS1 promoter from potato (Stockhaus et al.,  EMBO J  8:2445-2451 (1989)), the serine/threonine kinase (PAL) promoter and the glucoamylase (CHS) promoter from  Arabidopsis thaliana.  Also reported to be active in photosynthetically active tissues are the ribulose-1,5-bisphosphate carboxylase (RbcS) promoter from eastern larch ( Larix laricina ), the promoter for the cab gene, cab6, from pine (Yamamoto et al.,  Plant Cell Physiol.  35:773-778 (1994)), the promoter for the Cab-1 gene from wheat (Fejes et al.,  Plant Mol. Biol.  15:921-932 (1990)), the promoter for the CAB-1 gene from spinach (Lubberstedt et al.,  Plant Physiol.  104:997-1006 (1994)), the promoter for the cab1R gene from rice (Luan et al.,  Plant Cell.  4:971-981 (1992)), the pyruvate, orthophosphate dikinase (PPDK) promoter from corn (Matsuoka et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 90:9586-9590 (1993)), the promoter for the tobacco Lhcb1*2 gene (Cerdan et al.,  Plant Mol. Biol.  33:245-255 (1997)), the  Arabidopsis thaliana  SUC2 sucrose-H+symporter promoter (Truernit et al.,  Planta.  196:564-570 (1995)) and the promoter for the thylakoid membrane proteins from spinach (psaD, psaF, psaE, PC, FNR, atpC, atpD, cab, rbcS). Other promoters for the chlorophyll a/b-binding proteins may also be utilized in the invention, such as the promoters for LhcB gene and PsbP gene from white mustard ( Sinapis alba;  Kretsch et al.,  Plant Mol. Biol.  28:219-229 (1995)).  
           [0137]    A number of promoters for genes with tuber-specific or tuber-enhanced expression are known and can be used, including the class I patatin promoter (Bevan et al.,  EMBO J.  8:1899-1906 (1986); Jefferson et al.,  Plant Mol. Biol.  14:995-1006 (1990)), the promoter for the potato tuber ADPGPP genes, both the large and small subunits, the sucrose synthase promoter (Salanoubat and Belliard,  Gene  60:47-56 (1987), Salanoubat and Belliard,  Gene  84:181-185 (1989)), the promoter for the major tuber proteins including the 22 kd protein complexes and protease inhibitors (Hannapel,  Plant Physiol.  101:703-704 (1993)), the promoter for the granule-bound starch synthase gene (GBSS) (Visser et al.,  Plant Mol. Biol.  17:691-699 (1991)) and other class I and II patatins promoters (Koster-Topfer et al.,  Mol. Gen. Genet.  219:390-396 (1989); Mignery et al.,  Gene.  62:27-44 (1988)).  
           [0138]    Root specific promoters may also be used. An example of such a promoter is the promoter for the acid chitinase gene (Samac et al.,  Plant Mol. Biol.  25:587-596 (1994)). Expression in root tissue could also be accomplished by utilizing the root specific subdomains of the CaMV35S promoter that have been identified (Lam et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 86:7890-7894 (1989)). Other root cell specific promoters include those reported by Conkling et al. (Conkling et al.,  Plant Physiol.  93:1203-1211 (1990)).  
           [0139]    Additional promoters that may be utilized are described, for example, in U.S. Pat. Nos. 5,378,619; 5,391,725; 5,428,147; 5,447,858; 5,608,144; 5,608,144; 5,614,399; 5,633,441; 5,633,435; and 4,633,436. In addition, a tissue specific enhancer may be used (Fromm et al.,  The Plant Cell  1:977-984 (1989)).  
           [0140]    Constructs or vectors may also include, with the region of interest, a nucleic acid sequence that acts, in whole or in part, to terminate transcription of that region. A number of such sequences have been isolated, including the Tr7 3′ sequence and the NOS 3′ sequence (Ingelbrecht et al.,  The Plant Cell  1:671-680 (1989); Bevan et al.,  Nucleic Acids Res.  11:369-385 (1983)). Regulatory transcript termination regions can be provided in plant expression constructs of this invention as well. Transcript termination regions can be provided by the DNA sequence encoding the gene of interest or a convenient transcription termination region derived from a different gene source, for example, the transcript termination region that is naturally associated with the transcript initiation region. The skilled artisan will recognize that any convenient transcript termination region that is capable of terminating transcription in a plant cell can be employed in the constructs of the present invention.  
           [0141]    A vector or construct may also include regulatory elements. Examples of such include the Adh intron 1 (Callis et al.,  Genes and Develop.  1:1183-1200 (1987)), the sucrose synthase intron (Vasil et al.,  Plant Physiol.  91:1575-1579 (1989)) and the TMV omega element (Gallie et al.,  The Plant Cell  1:301-311 (1989)). These and other regulatory elements may be included when appropriate.  
           [0142]    A vector or construct may also include a selectable marker. Selectable markers may also be used to select for plants or plant cells that contain the exogenous genetic material. Examples of such include, but are not limited to: a neo gene (Potrykus et al.,  Mol. Gen. Genet.  199:183-188 (1985)), which codes for kanamycin resistance and can be selected for using kanamycin, RptII, G418, hpt; a bar gene which codes for bialaphos resistance; a mutant EPSP synthase gene (Hinchee et al.,  Bio/Technology  6:915-922 (1988); Reynaerts et al., Selectable and Screenable Markers. In Gelvin and Schilperoort. Plant Molecular Biology Manual, Kluwer, Dordrecht (1988); Reynaerts et al., Selectable and screenable markers. In Gelvin and Schilperoort. Plant Molecular Biology Manual, Kluwer, Dordrecht (1988)), aadA (Jones et al.,  Mol. Gen. Genet.  (1987)),) which encodes glyphosate resistance; a nitrilase gene which confers resistance to bromoxynil (Stalker et al.,  J. Biol. Chem.  263:6310-6314 (1988)); a mutant acetolactate synthase gene (ALS) which confers imidazolinone or sulphonylurea resistance (European Patent Application 154,204 (Sep. 11, 1985)), ALS (D&#39;Halluin et al., Bio/Technology 10:309-314 (1992)), and a methotrexate resistant DHFR gene (Thillet et al.,  J. Biol. Chem.  263:12500-12508 (1988)).  
           [0143]    A vector or construct may also include a screenable marker. Screenable markers may be used to monitor expression. Exemplary screenable markers include: a β-glucuronidase or uidA gene (GUS) which encodes an enzyme for which various chromogenic substrates are known (Jefferson,  Plant Mol. Biol, Rep.  5:387-405 (1987); Jefferson et al.,  EMBO J.  6:3901-3907 (1987)); an R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al., Stadler Symposium 11:263-282 (1988)); a β-lactamase gene (Sutcliffe et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 75:3737-3741 (1978)), a gene which encodes an enzyme for which various chromogenic substrates are known (e.g., PADAC, a chromogenic cephalosporin); a luciferase gene (Ow et al.,  Science  234:856-859 (1986)); a xy/E gene (Zukowsky et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 80:1101-1105 (1983)) which encodes a catechol dioxygenase that can convert chromogenic catechols; an α-amylase gene (Ikatu et al.,  Bio/Technol.  8:241-242 (1990)); a tyrosinase gene (Katz et al.,  J. Gen. Microbiol.  129:2703-2714 (1983)) which encodes an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone which in turn condenses to melanin; an α-galactosidase, which will turn a chromogenic α-galactose substrate.  
           [0144]    Included within the terms “selectable or screenable marker genes” are also genes that encode a secretable marker whose secretion can be detected as a means of identifying or selecting for transformed cells. Examples include markers that encode a secretable antigen that can be identified by antibody interaction, or even secretable enzymes that can be detected catalytically. Secretable proteins fall into a number of classes, including small, diffusible proteins that are detectable, (e.g., by ELISA), small active enzymes that are detectable in extracellular solution (e.g., α-amylase, β-lactamase, phosphinothricin transferase), or proteins that are inserted or trapped in the cell wall (such as proteins that include a leader sequence such as that found in the expression unit of extension or tobacco PR-S). Other possible selectable and/or screenable marker genes will be apparent to those of skill in the art.  
           [0145]    It is understood that two or more nucleic molecules of the present invention may be introduced into a plant using a single construct and that construct can contain more than one promoter. In embodiments where the construct is designed to express two nucleic acid molecules, it is preferred that the two promoters are (i) two constitutive promoters, (ii) two seed-specific promoters, or (iii) one constitutive promoter and one seed-specific promoter. Preferred seed-specific and constitutive promoters are a napin and a CaMV promoter, respectively. Illustrative combinations are set forth in Example 7. It is understood that two or more of the nucleic molecules may be physically linked and expressed utilizing a single promoter, preferably a seed-specific or constitutive promoter.  
           [0146]    There are many methods for introducing transforming nucleic acid molecules into plant cells. Suitable methods are believed to include virtually any method by which nucleic acid molecules may be introduced into a cell, such as by Agrobacterium infection or direct delivery of nucleic acid molecules such as, for example, by PEG-mediated transformation, by electroporation or by acceleration of DNA coated particles, and the like. (Potrykus,  Ann. Rev. Plant Physiol. Plant Mol. Biol.  42:205-225 (1991); Vasil,  Plant Mol. Biol.  25:925-937 (1994)). For example, electroporation has been used to transform corn protoplasts (Fromm et al.,  Nature  312:791-793 (1986)).  
           [0147]    Other vector systems suitable for introducing transforming DNA into a host plant cell include but are not limited to binary artificial chromosome (BIBAC) vectors (Hamilton et al.,  Gene  200,107-116 (1997)); and transfection with RNA viral vectors (Della-Cioppa et al.,  Ann. N. Y. Acad. Sci.  (1996), 792 (Engineering Plants for Commercial Products and Applications), 57-61). Additional vector systems also include plant selectable YAC vectors such as those described in Mullen et al.,  Molecular Breeding  4:449-457 (1988).  
           [0148]    Technology for introduction of DNA into cells is well known to those of skill in the art. Four general methods for delivering a gene into cells have been described: (1) chemical methods (Graham and van der Eb,  Virology  54:536-539 (1973)); (2) physical methods such as microinjection (Capecchi,  Cell  22:479-488 (1980)), electroporation (Wong and Neumann,  Biochem. Biophys. Res. Commun.  107:584-587 (1982); Fromm et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 82:5824-5828 (1985); U.S. Pat. No. 5,384,253); the gene gun (Johnston and Tang,  Methods Cell Biol.  43:353-365 (1994)); and vacuum infiltration (Bechtold et al.,  C.R. Acad. Sci. Paris, Life Sci.  316:1194-1199. (1993)); (3) viral vectors (Clapp,  Clin. Perinatol.  20:155-168 (1993); Lu et al.,  J. Exp. Med.  178:2089-2096 (1993); Eglitis and Anderson,  Biotechniques  6:608-614 (1988)); and (4) receptor-mediated mechanisms (Curiel et al.,  Hum. Gen. Ther.  3: 147-154 (1992), Wagner et al.,  Proc. Natl. Acad. Sci.  ( USA ) 89:6099-6103 (1992)).  
           [0149]    Acceleration methods that may be used include, for example, microprojectile bombardment and the like. One example of a method for delivering transforming nucleic acid molecules into plant cells is microprojectile bombardment. This method has been reviewed by Yang and Christou (eds.),  Particle Bombardment Technology for Gene Transfer,  Oxford Press, Oxford, England (1994)). Non-biological particles (microprojectiles) may be coated with nucleic acid molecules and delivered into cells by a propelling force. Exemplary particles include those comprised of tungsten, gold, platinum and the like.  
           [0150]    A particular advantage of microprojectile bombardment, in addition to it being an effective means of reproducibly transforming monocots, is that neither the isolation of protoplasts (Cristou et al.,  Plant Physiol.  87:671-674 (1988)) nor the susceptibility to Agrobacterium infection is required. An illustrative embodiment of a method for delivering DNA into corn cells by acceleration is a biolistics α-particle delivery system, which can be used to propel particles coated with DNA through a screen, such as a stainless steel or Nytex screen, onto a filter surface covered with corn cells cultured in suspension. Gordon-Kamm et al., describes the basic procedure for coating tungsten particles with DNA (Gordon-Kamm et al.,  Plant Cell  2:603-618 (1990)). The screen disperses the tungsten nucleic acid particles so that they are not delivered to the recipient cells in large aggregates. A particle delivery system suitable for use with the invention is the helium acceleration PDS-1000/He gun, which is available from Bio-Rad Laboratories (Bio-Rad, Hercules, Calif.)(Sanford et al.,  Technique  3:3-16 (1991)).  
           [0151]    For the bombardment, cells in suspension may be concentrated on filters. Filters containing the cells to be bombarded are positioned at an appropriate distance below the microprojectile stopping plate. If desired, one or more screens are also positioned between the gun and the cells to be bombarded.  
           [0152]    Alternatively, immature embryos or other target cells may be arranged on solid culture medium. The cells to be bombarded are positioned at an appropriate distance below the microprojectile stopping plate. If desired, one or more screens are also positioned between the acceleration device and the cells to be bombarded. Through the use of techniques set forth herein one may obtain 1000 or more loci of cells transiently expressing a marker gene. The number of cells in a focus that express the exogenous gene product 48 hours post-bombardment often ranges from one to ten, and average one to three.  
           [0153]    In bombardment transformation, one may optimize the pre-bombardment culturing conditions and the bombardment parameters to yield the maximum numbers of stable transformants. Both the physical and biological parameters for bombardment are important in this technology. Physical factors are those that involve manipulating the DNA/microprojectile precipitate or those that affect the flight and velocity of either the macro- or microprojectiles. Biological factors include all steps involved in manipulation of cells before and immediately after bombardment, the osmotic adjustment of target cells to help alleviate the trauma associated with bombardment and also the nature of the transforming DNA, such as linearized DNA or intact supercoiled plasmids. It is believed that pre-bombardment manipulations are especially important for successful transformation of immature embryos.  
           [0154]    Accordingly, it is contemplated that one may wish to adjust various aspects of the bombardment parameters in small scale studies to fully optimize the conditions. One may particularly wish to adjust physical parameters such as gap distance, flight distance, tissue distance and helium pressure. One may also minimize the trauma reduction factors by modifying conditions that influence the physiological state of the recipient cells and which may therefore influence transformation and integration efficiencies. For example, the osmotic state, tissue hydration and the subculture stage or cell cycle of the recipient cells may be adjusted for optimum transformation. The execution of other routine adjustments will be known to those of skill in the art in light of the present disclosure.  
           [0155]    Agrobacterium-mediated transfer is a widely applicable system for introducing genes into plant cells because the DNA can be introduced into whole plant tissues, thereby bypassing the need for regeneration of an intact plant from a protoplast. The use of Agrobacterium-mediated plant integrating vectors to introduce DNA into plant cells is well known in the art. See, for example the methods described by Fraley et al.,  Bio/Technology  3:629-635 (1985) and Rogers et al.,  Methods Enzymol.  153:253-277 (1987). Further, the integration of the Ti-DNA is a relatively precise process resulting in few rearrangements. The region of DNA to be transferred is defined by the border sequences and intervening DNA is usually inserted into the plant genome as described (Spielmann et al.,  Mol. Gen. Genet.  205:34 (1986)).  
           [0156]    Modern Agrobacterium transformation vectors are capable of replication in  E. coli  as well as Agrobacterium, allowing for convenient manipulations as described (Klee et al., In:  Plant DNA Infectious Agents,  Hohn and Schell (eds.), Springer-Verlag, New York, pp. 179-203 (1985)). Moreover, technological advances in vectors for Agrobacterium-mediated gene transfer have improved the arrangement of genes and restriction sites in the vectors to facilitate construction of vectors capable of expressing various polypeptide coding genes. The vectors described have convenient multi-linker regions flanked by a promoter and a polyadenylation site for direct expression of inserted polypeptide coding genes and are suitable for present purposes (Rogers et al.,  Methods Enzymol.  153:253-277 (1987)). In addition, Agrobacterium containing both armed and disarmed Ti genes can be used for the transformations. In those plant strains where Agrobacterium-mediated transformation is efficient, it is the method of choice because of the facile and defined nature of the gene transfer.  
           [0157]    A transgenic plant formed using Agrobacterium transformation methods typically contains a single gene on one chromosome. Such transgenic plants can be referred to as being heterozygous for the added gene. More preferred is a transgenic plant that is homozygous for the added structural gene; i.e., a transgenic plant that contains two added genes, one gene at the same locus on each chromosome of a chromosome pair. A homozygous transgenic plant can be obtained by sexually mating (selfing) an independent segregant, transgenic plant that contains a single added gene, germinating some of the seed produced and analyzing the resulting plants produced for the gene of interest.  
           [0158]    It is also to be understood that two different transgenic plants can also be mated to produce offspring that contain two independently segregating, exogenous genes. Selfing of appropriate progeny can produce plants that are homozygous for both added, exogenous genes that encode a polypeptide of interest. Back-crossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated, as is vegetative propagation.  
           [0159]    In a preferred embodiment, a plant of the present invention that includes nucleic acid sequences which when expressed are capable of selectively reducing a FAD2 gene is mated with another plant of the present invention that includes nucleic acid sequences which when expressed are capable of selectively reducing a FAD3 gene.  
           [0160]    Transformation of plant protoplasts can be achieved using methods based on calcium phosphate precipitation, polyethylene glycol treatment, electroporation and combinations of these treatments (See, for example, Potrykus et al.,  Mol. Gen. Genet.  205:193-200 (1986); Lorz et al.,  Mol. Gen. Genet.  199:178 (1985); Fromm et al.,  Nature  319:791 (1986); Uchimiya et al.,  Mol. Gen. Genet.  204:204 (1986); Marcotte et al.,  Nature  335:454-457 (1988)).  
           [0161]    Application of these systems to different plant strains depends upon the ability to regenerate that particular plant strain from protoplasts. Illustrative methods for the regeneration of cereals from protoplasts are described (Fujimura et al.,  Plant Tissue Culture Letters  2:74 (1985); Toriyama et al.,  Theor. Appl. Genet.  205:34 (1986); Yamada et al.,  Plant Cell Rep.  4:85 (1986); Abdullah et al.,  Biotechnology  4:1087 (1986)).  
           [0162]    To transform plant strains that cannot be successfully regenerated from protoplasts, other ways to introduce DNA into intact cells or tissues can be utilized. For example, regeneration of cereals from immature embryos or explants can be effected as described (Vasil,  Biotechnology  6:397 (1988)). In addition, “particle gun” or high-velocity microprojectile technology can be utilized (Vasil et al.,  Bio/Technology  10:667 (1992)).  
           [0163]    Using the latter technology, DNA is carried through the cell wall and into the cytoplasm on the surface of small metal particles as described (Klein et al.,  Nature  328:70 (1987); Klein et al.,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 85:8502-8505 (1988); McCabe et al.,  Bio/Technology  6:923 (1988)). The metal particles penetrate through several layers of cells and thus allow the transformation of cells within tissue explants.  
           [0164]    Other methods of cell transformation can also be used and include but are not limited to introduction of DNA into plants by direct DNA transfer into pollen (Hess et al.,  Intern Rev. Cytol.  107:367 (1987); Luo et al.,  Plant Mol Biol. Reporter  6:165 (1988)), by direct injection of DNA into reproductive organs of a plant (Pena et al.,  Nature  325:274 (1987)), or by direct injection of DNA into the cells of immature embryos followed by the rehydration of desiccated embryos (Neuhaus et al.,  Theor. Appl. Genet.  75:30 (1987)).  
           [0165]    The regeneration, development and cultivation of plants from single plant protoplast transformants or from various transformed explants is well known in the art (Weissbach and Weissbach, In:  Methods for Plant Molecular Biology,  Academic Press, San Diego, Calif., (1988)). This regeneration and growth process typically includes the steps of selection of transformed cells, culturing those individualized cells through the usual stages of embryonic development through the rooted plantlet stage. Transgenic embryos and seeds are similarly regenerated. The resulting transgenic rooted shoots are thereafter planted in an appropriate plant growth medium such as soil.  
           [0166]    The development or regeneration of plants containing the foreign, exogenous gene that encodes a protein of interest is well known in the art. Preferably, the regenerated plants are self-pollinated to provide homozygous transgenic plants. Otherwise, pollen obtained from the regenerated plants is crossed to seed-grown plants of agronomically important lines. Conversely, pollen from plants of these important lines is used to pollinate regenerated plants. A transgenic plant of the invention containing a desired polypeptide is cultivated using methods well known to one skilled in the art.  
           [0167]    There are a variety of methods for the regeneration of plants from plant tissue. The particular method of regeneration will depend on the starting plant tissue and the particular plant species to be regenerated.  
           [0168]    Methods for transforming dicots, primarily by use of  Agrobacterium tumefaciens  and obtaining transgenic plants have been published for cotton (U.S. Pat. No. 5,004,863; U.S. Pat. No. 5,159,135; U.S. Pat. No. 5,518,908); soybean (U.S. Pat. No. 5,569,834; U.S. Pat. No. 5,416,011; McCabe et al.,  Biotechnology  6:923 (1988); Christou et al.,  Plant Physiol.  87:671-674 (1988));  Brassica  (U.S. Pat. No. 5,463,174); peanut (Cheng et al.,  Plant Cell Rep.  15:653-657 (1996), McKently et al.,  Plant Cell Rep.  14:699-703 (1995)); papaya; pea (Grant et al.,  Plant Cell Rep.  15:254-258 (1995)); and  Arabidopsis thaliana  (Bechtold et al.,  C.R. Acad. Sci. Paris, Life Sci.  316:1194-1199 (1993)). The latter method for transforming  Arabidopsis thaliana  is commonly called “dipping” or vacuum infiltration or germplasm transformation.  
           [0169]    Transformation of monocotyledons using electroporation, particle bombardment and Agrobacterium have also been reported. Transformation and plant regeneration have been achieved in asparagus (Bytebier et al.,  Proc. Natl. Acad. Sci.  ( USA ) 84:5354 (1987)); barley (Wan and Lemaux,  Plant Physiol  104:37 (1994)); corn (Rhodes et al.,  Science  240:204 (1988); Gordon-Kamm et al.,  Plant Cell  2:603-618 (1990); Fromm et al.,  Bio/Technology  8:833 (1990); Koziel et al.,  Bio/Technology  11:194 (1993); Armstrong et al.,  Crop Science  35:550-557 (1995)); oat (Somers et al,  Bio/Technology  10:1589 (1992)); orchard grass (Horn et al.,  Plant Cell Rep.  7:469 (1988)); rice (Toriyama et al.,  Theor Appl. Genet.  205:34 (1986); Part et al.,  Plant Mol. Biol.  32:1135-1148 (1996); Abedinia et al.,  Aust. J. Plant Physiol.  24:133-141 (1997); Zhang and Wu,  Theor. Appl. Genet.  76:835 (1988); Zhang et al.,  Plant Cell Rep.  7:379 (1988); Battraw and Hall,  Plant Sci.  86:191-202 (1992); Christou et al.,  Bio/Technology  9:957 (1991)); rye (De la Pena et al.,  Nature  325:274 (1987)); sugarcane (Bower and Birch,  Plant J.  2:409 (1992)); tall fescue (Wang et al.,  Bio/Technology  10:691 (1992)) and wheat (Vasil et al.,  Bio/Technology  10:667 (1992); U.S. Pat. No. 5,631,152).  
           [0170]    Assays for gene expression based on the transient expression of cloned nucleic acid constructs have been developed by introducing the nucleic acid molecules into plant cells by polyethylene glycol treatment, electroporation, or particle bombardment (Marcotte et al.,  Nature  335:454-457 (1988); Marcotte et al.,  Plant Cell  1:523-532 (1989); McCarty et al.,  Cell  66:895-905 (1991); Hattori et al.,  Genes Dev.  6:609-618 (1992); Goffet al.,  EMBO J.  9:2517-2522 (1990)). Transient expression systems may be used to functionally dissect gene constructs (see generally, Maliga et al.,  Methods in Plant Molecular Biology,  Cold Spring Harbor Press (1995)).  
           [0171]    Any of the nucleic acid molecules of the invention may be introduced into a plant cell in a permanent or transient manner in combination with other genetic elements, for example, including but not limited to, vectors, promoters, and enhancers. Further, any of the nucleic acid molecules of the invention may be introduced into a plant cell in a manner that allows for expression or overexpression of the protein or fragment thereof encoded by the nucleic acid molecule.  
           [0172]    Cosuppression is the reduction in expression levels, usually at the level of RNA, of a particular endogenous gene or gene family by the expression of a homologous sense construct that is capable of transcribing mRNA of the same strandedness as the transcript of the endogenous gene (Napoli et al.,  Plant Cell  2:279-289 (1990); van der Krol et al.,  Plant Cell  2:291-299 (1990)). Cosuppression may result from stable transformation with a single copy nucleic acid molecule that is homologous to a nucleic acid sequence found with the cell (Prolls and Meyer,  Plant J.  2:465-475 (1992)) or with multiple copies of a nucleic acid molecule that is homologous to a nucleic acid sequence found with the cell (Mittlesten et al.,  Mol. Gen. Genet.  244:325-330 (1994)). Genes, even though different, linked to homologous promoters may result in the cosuppression of the linked genes (Vaucheret,  C.R. Acad. Sci. III  1316:1471-1483 (1993); Flavell,  Proc. Natl. Acad. Sci.  ( U.S.A. ) 91:3490-3496 (1994)); van Blokland et al.,  Plant J.  6:861-877 (1994); Jorgensen,  Trends Biotechnol.  8:340-344 (1990); Meins and Kunz, In:  Gene Inactivation and Homologous Recombination in Plants,  Paszkowski (ed.), pp. 335-348, Kluwer Academic, Netherlands (1994))(Kinney, Induced Mutations and Molecular Techniques for Crop Improvement, Proceedings of a Symposium 19-23 June 1995 jointly organized by IAEA and FA)), pages 101 -113 (IAEA-SM 340-49).  
           [0173]    It is understood that one or more of the nucleic acids of the invention may be introduced into a plant cell and transcribed using an appropriate promoter with such transcription resulting in the cosuppression of an endogenous protein.  
           [0174]    Antisense approaches are a way of preventing or reducing gene function by targeting the genetic material (Mol et al.,  FEBS Lett.  268:427-430 (1990)). The objective of the antisense approach is to use a sequence complementary to the target gene to block its expression and create a mutant cell line or organism in which the level of a single chosen protein is selectively reduced or abolished. Antisense techniques have several advantages over other ‘reverse genetic’ approaches. The site of inactivation and its developmental effect can be manipulated by the choice of promoter for antisense genes or by the timing of external application or microinjection. Antisense can manipulate its specificity by selecting either unique regions of the target gene or regions where it shares homology to other related genes (Hiatt et al., In:  Genetic Engineering,  Setlow (ed.), Vol. 11, New York: Plenum 49-63 (1989)).  
           [0175]    Antisense RNA techniques involve introduction of RNA that is complementary to the target mRNA into cells, which results in specific RNA:RNA duplexes being formed by base pairing between the antisense substrate and the target mRNA (Green et al.,  Annu. Rev. Biochem.  55:569-597 (1986)). Under one embodiment, the process involves the introduction and expression of an antisense gene sequence. Such a sequence is one in which part or all of the normal gene sequences are placed under a promoter in inverted orientation so that the ‘wrong’ or complementary strand is transcribed into a noncoding antisense RNA that hybridizes with the target mRNA and interferes with its expression (Takayama and Inouye,  Crit. Rev. Biochem. Mol. Biol.  25:155-184 (1990)). An antisense vector is constructed by standard procedures and introduced into cells by methods including but not limited to transformation, transfection, electroporation, microinjection, and infection. The type of transformation and choice of vector will determine whether expression is transient or stable. The promoter used for the antisense gene may influence the level, timing, tissue, specificity, or inducibility of the antisense inhibition.  
           [0176]    It has been reported that the introduction of double-stranded RNA into cells may also be used to disrupt the function of an endogenous gene. (Fire et al.,  Nature  391:806-811 (1998)). Such disruption has been demonstrated, for example, in  Caenorhabditis elegans  and is often referred to as RNA interference, or RNAi. (Fire et al.,  Nature  391:806-811 (1998)). The disruption of gene expression in  C. elegans  by double-stranded RNA has been reported to induce suppression by a post-transcriptional mechanism. (Montgomery et al., Proc. Natl. Acad. Sci. 95:15502-15507 (1998)). Evidence of gene silencing by double-stranded RNA has also been reported for plants. (Waterhouse et al.,  Proc. Natl. Acad. Sci.  95:13959-13964 (1998)).  
           [0177]    An intron-spliced hairpin structure reportedly may also be used to effect post-transcriptional gene suppression. (Smith et al.,  Nature  407:319-320 (2000)). Reports indicate that post-transcriptional gene silencing can be induced with almost 100% efficiency by the use of intron-spliced RNA with a hairpin structure. (Smith et al.,  Nature  407:319-320 (2000)).  
           [0178]    It is understood that one or more of the nucleic acids of the invention may be modified in order to effect RNAi or another mode of post-transcriptional gene suppression.  
           [0179]    The present invention also provides for parts of the plants, particularly reproductive or storage parts. Plant parts, without limitation, include seed, endosperm, ovule, pollen, roots, tubers, stems, leaves, stalks, fruit, berries, nuts, bark, pods, seeds and flowers. In a particularly preferred embodiment of the present invention, the plant part is a seed.  
           [0180]    The present invention also provides a container of over 10,000, more preferably 20,000, and even more preferably 40,000 seeds where over 10%, more preferably 25%, more preferably 50% and even more preferably 75% or 90% of the seeds are seeds derived from a plant of the present invention.  
           [0181]    The present invention also provides a container of over 10 kg, more preferably 25 kg, and even more preferably 50 kg seeds where over 10%, more preferably 25%, more preferably 50% and even more preferably 75% or 90% of the seeds are seeds derived from a plant of the present invention.  
           [0182]    Any of the plants or parts thereof of the present invention may be processed to produce a feed, meal, protein, or oil preparation. A particularly preferred plant part for this purpose is a seed. In a preferred embodiment the feed, meal, protein or oil preparation is designed for livestock animals or humans, or both. Methods to produce feed, meal, protein and oil preparations are known in the art. See, for example, U.S. Pat. Nos. 4,957,748, 5,100,679, 5,219,596, 5,936,069, 6,005,076, 6,146,669, and 6,156,227. In a preferred embodiment, the protein preparation is a high protein preparation. Such a high protein preparation preferably has a protein content of greater than 5% w/v, more preferably 10% w/v, and even more preferably 15% w/v. In a preferred oil preparation, the oil preparation is a high oil preparation with an oil content derived from a plant or part thereof of the present invention of greater than 5% w/v, more preferably 10% w/v, and even more preferably 15% w/v. In a preferred embodiment the oil preparation is a liquid and of a volume greater than 1, 5, 10 or 50 liters. The present invention provides for oil produced from plants of the present invention or generated by a method of the present invention. Such an oil may exhibit enhanced oxidative stability. Also, such oil may be a minor or major component of any resultant product. Moreover, such oil may be blended with other oils. In a preferred embodiment, the oil produced from plants of the present invention or generated by a method of the present invention constitutes greater than 0.5%, 1%, 5%, 10%, 25%, 50%, 75% or 90% by volume or weight of the oil component of any product. In another embodiment, the oil preparation may be blended and can constitute greater than 10%, 25%, 35%, 50% or 75% of the blend by volume. Oil produced from a plant of the present invention can be admixed with one or more organic solvents or petroleum distillates.  
           [0183]    In one embodiment, an oil of the present invention has an oil composition that is 50% or greater oleic acid and 10% or less linolenic acid. In another embodiment, an oil of the present invention has an oil composition that is 60% or greater oleic acid and 7% or less linolenic acid. In another embodiment, an oil of the present invention has an oil composition that is 65% or greater oleic acid and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid.  
           [0184]    In another embodiment, an oil of the present invention has an oil composition that is between 50% and 90% oleic acid and 10% or less linolenic acid. In another embodiment, an oil of the present invention has an oil composition that is between 60% and 80% oleic acid and 7% or less linolenic acid. In another embodiment, an oil of the present invention has an oil composition that is between 65% and 75% oleic acid and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid.  
           [0185]    In another embodiment, an oil of the present invention has an oil composition that is 80% or greater, more preferably 90% or greater oleic acid and 5% or less linolenic acid, preferably 4% or less linolenic acid, and more preferably 3% or less linolenic acid. In another embodiment, an oil of the present invention has an oil composition that is 50% or greater oleic acid, more preferably 60% or greater, 70% or greater, 80% or greater, or 90% or greater oleic acid. In another embodiment, an oil of the present invention has an oil composition that is 10% or less linolenic acid, preferably 5% or less, 4% or less, or 3% or less linolenic acid.  
           [0186]    Plants of the present invention can be part of or generated from a breeding program. The choice of breeding method depends on the mode of plant reproduction, the heritability of the trait(s) being improved, and the type of cultivar used commercially (e.g., F 1  hybrid cultivar, pureline cultivar, etc). Selected, non-limiting approaches, for breeding the plants of the present invention are set forth below. A breeding program can be enhanced using marker assisted selection of the progeny of any cross. It is further understood that any commercial and non-commercial cultivars can be utilized in a breeding program. Factors such as, for example, emergence vigor, vegetative vigor, stress tolerance, disease resistance, branching, flowering, seed set, seed size, seed density, standability, and threshability will generally dictate the choice.  
           [0187]    For highly heritable traits, a choice of superior individual plants evaluated at a single location will be effective, whereas for traits with low heritability, selection should be based on mean values obtained from replicated evaluations of families of related plants. Popular selection methods commonly include pedigree selection, modified pedigree selection, mass selection, and recurrent selection. In a preferred embodiment a backcross or recurrent breeding program is undertaken.  
           [0188]    The complexity of inheritance influences choice of the breeding method. Backcross breeding can be used to transfer one or a few favorable genes for a highly heritable trait into a desirable cultivar. This approach has been used extensively for breeding disease-resistant cultivars. Various recurrent selection techniques are used to improve quantitatively inherited traits controlled by numerous genes. The use of recurrent selection in self-pollinating crops depends on the ease of pollination, the frequency of successful hybrids from each pollination, and the number of hybrid offspring from each successful cross.  
           [0189]    Breeding lines can be tested and compared to appropriate standards in environments representative of the commercial target area(s) for two or more generations. The best lines are candidates for new commercial cultivars; those still deficient in traits may be used as parents to produce new populations for further selection.  
           [0190]    One method of identifying a superior plant is to observe its performance relative to other experimental plants and to a widely grown standard cultivar. If a single observation is inconclusive, replicated observations can provide a better estimate of its genetic worth. A breeder can select and cross two or more parental lines, followed by repeated selfing and selection, producing many new genetic combinations.  
           [0191]    The development of new cultivars requires the development and selection of varieties, the crossing of these varieties and the selection of superior hybrid crosses. The hybrid seed can be produced by manual crosses between selected male-fertile parents or by using male sterility systems. Hybrids are selected for certain single gene traits such as pod color, flower color, seed yield, pubescence color, or herbicide resistance, which indicate that the seed is truly a hybrid. Additional data on parental lines, as well as the phenotype of the hybrid, influence the breeder&#39;s decision whether to continue with the specific hybrid cross.  
           [0192]    Pedigree breeding and recurrent selection breeding methods can be used to develop cultivars from breeding populations. Breeding programs combine desirable traits from two or more cultivars or various broad-based sources into breeding pools from which cultivars are developed by selfing and selection of desired phenotypes. New cultivars can be evaluated to determine which have commercial potential.  
           [0193]    Pedigree breeding is used commonly for the improvement of self-pollinating crops. Two parents who possess favorable, complementary traits are crossed to produce an F 1 . A F 2  population is produced by selfing one or several F 1 &#39;s. Selection of the best individuals from the best families is carried out. Replicated testing of families can begin in the F 4  generation to improve the effectiveness of selection for traits with low heritability. At an advanced stage of inbreeding (i.e., F 6  and F 7 ), the best lines or mixtures of phenotypically similar lines are tested for potential release as new cultivars.  
           [0194]    Backcross breeding has been used to transfer genes for a simply inherited, highly heritable trait into a desirable homozygous cultivar or inbred line, which is the recurrent parent. The source of the trait to be transferred is called the donor parent. The resulting plant is expected to have the attributes of the recurrent parent (e.g., cultivar) and the desirable trait transferred from the donor parent. After the initial cross, individuals possessing the phenotype of the donor parent are selected and repeatedly crossed (backcrossed) to the recurrent parent. The resulting parent is expected to have the attributes of the recurrent parent (e.g., cultivar) and the desirable trait transferred from the donor parent.  
           [0195]    The single-seed descent procedure in the strict sense refers to planting a segregating population, harvesting a sample of one seed per plant, and using the one-seed sample to plant the next generation. When the population has been advanced from the F 2  to the desired level of inbreeding, the plants from which lines are derived will each trace to different F 2  individuals. The number of plants in a population declines each generation due to failure of some seeds to germinate or some plants to produce at least one seed. As a result, not all of the F 2  plants originally sampled in the population will be represented by a progeny when generation advance is completed.  
           [0196]    In a multiple-seed procedure, breeders commonly harvest one or more pods from each plant in a population and thresh them together to form a bulk. Part of the bulk is used to plant the next generation and part is put in reserve. The procedure has been referred to as modified single-seed descent or the pod-bulk technique.  
           [0197]    The multiple-seed procedure has been used to save labor at harvest. It is considerably faster to thresh pods with a machine than to remove one seed from each by hand for the single-seed procedure. The multiple-seed procedure also makes it possible to plant the same number of seed of a population each generation of inbreeding.  
           [0198]    Descriptions of other breeding methods that are commonly used for different traits and crops can be found in one of several reference books (e.g. Fehr,  Principles of Cultivar Development  Vol. 1, pp. 2-3 (1987))).  
           [0199]    A transgenic plant of the present invention may also be reproduced using apomixis. Apomixis is a genetically controlled method of reproduction in plants where the embryo is formed without union of an egg and a sperm. There are three basic types of apomictic reproduction: 1) apospory where the embryo develops from a chromosomally unreduced egg in an embryo sac derived from the nucleus, 2) diplospory where the embryo develops from an unreduced egg in an embryo sac derived from the megaspore mother cell, and 3) adventitious embryony where the embryo develops directly from a somatic cell. In most forms of apomixis, pseudogamy or fertilization of the polar nuclei to produce endosperm is necessary for seed viability. In apospory, a nurse cultivar can be used as a pollen source for endosperm formation in seeds. The nurse cultivar does not affect the genetics of the aposporous apomictic cultivar since the unreduced egg of the cultivar develops parthenogenetically, but makes possible endosperm production. Apomixis is economically important, especially in transgenic plants, because it causes any genotype, no matter how heterozygous, to breed true. Thus, with apomictic reproduction, heterozygous transgenic plants can maintain their genetic fidelity throughout repeated life cycles. Methods for the production of apomictic plants are known in the art. See, U.S. Pat. No. 5,811,636.  
           [0200]    Computer Readable Medium  
           [0201]    The nucleotide sequence provided in SEQ ID NO:1 through 15, 18, 19, 22, 23, or fragment thereof or complement thereof, or a nucleotide sequence at least 50%, 60%, or 70% identical, preferably 80%, 85% identical, or especially preferably 90%, or 95% identical, or particularly highly preferably 97%, 98%, or 99% identical to the sequence provided in SEQ ID NO:1 through 15, 18, 19, 22, 23, or fragment thereof or complement thereof, can be “provided” in a variety of media to facilitate use. Such a medium can also provide a subset thereof in a form that allows a skilled artisan to examine the sequences.  
           [0202]    In one application of this embodiment, a nucleotide sequence of the present invention can be recorded on computer readable media. As used herein, “computer readable media” refers to any medium that can be read and accessed directly by a computer. Such media include, but are not limited to: magnetic storage media, such as floppy disk, hard disc, storage medium, and magnetic tape; optical storage media such as CD-ROM; electrical storage media such as RAM and ROM; and hybrids of these categories such as magnetic/optical storage media. A skilled artisan can readily appreciate how any of the presently known computer readable media can be used to create a manufacture comprising a computer readable medium having recorded thereon a nucleotide sequence of the present invention.  
           [0203]    As used herein, “recorded” refers to a process for storing information on computer readable medium. A skilled artisan can readily adopt any of the presently known methods for recording information on computer readable media to generate media comprising the nucleotide sequence information of the present invention. A variety of data storage structures are available to a skilled artisan for creating a computer readable medium having recorded thereon a nucleotide sequence of the present invention. The choice of the data storage structure will generally be based on the means chosen to access the stored information. In addition, a variety of data processor programs and formats can be used to store the nucleotide sequence information of the present invention on computer readable media. The sequence information can be represented in a word processing text file, formatted in commercially-available software such as Word Perfect and Microsoft Word, or represented in the form of an ASCII file, stored in a database application, such as DB2, Sybase, Oracle, or the like. A skilled artisan can readily adapt any number of data processor structuring formats (e.g. text file or database) in order to obtain computer readable media having recorded thereon the nucleotide sequence information of the present invention.  
           [0204]    By providing one or more nucleotide sequences of the present invention, a skilled artisan can routinely access the sequence information for a variety of purposes. Computer software is publicly available which allows a skilled artisan to access sequence information provided in a computer readable medium. Software which implements the BLAST (Altschul et al.,  J. Mol. Biol.  215:403-410 (1990)) and BLAZE (Brutlag et al.,  Comp. Chem.  17:203-207 (1993), the entirety of which is herein incorporated by reference) search algorithms on a Sybase system can be used to identify non-coding regions and other nucleic acid molecules of the present invention within the genome that contain homology to non-coding regions from other organisms. Such non-coding regions may be utilized to affect the expression of commercially important proteins such as enzymes used in amino acid biosynthesis, metabolism, transcription, translation, RNA processing, nucleic acid and protein degradation, protein modification, and DNA replication, restriction, modification, recombination, and repair.  
           [0205]    The present invention further provides systems, particularly computer-based systems, which contain the sequence information described herein. Such systems are designed to identify commercially important fragments of the nucleic acid molecules of the present invention. As used herein, “a computer-based system” refers to the hardware means, software means, and data storage means used to analyze the nucleotide sequence information of the present invention. The minimum hardware means of the computer-based systems of the present invention comprises a central processing unit (CPU), input means, output means, and data storage means. A skilled artisan can readily appreciate that any one of the currently available computer-based systems is suitable for use in the present invention.  
           [0206]    As indicated above, the computer-based systems of the present invention comprise a data storage means having stored therein a nucleotide sequence of the present invention and the necessary hardware means and software means for supporting and implementing a search means. As used herein, “data storage means” refers to memory that can store nucleotide sequence information of the present invention, or a memory access means which can access manufactures having recorded thereon the nucleotide sequence information of the present invention. As used herein, “search means” refers to one or more programs which are implemented on the computer-based system to compare a target sequence or target structural motif with the sequence information stored within the data storage means. Search means are used to identify fragments or regions of the sequence of the present invention that match a particular target sequence or target motif. A variety of known algorithms are disclosed publicly and a variety of commercially available software for conducting search means are available and can be used in the computer-based systems of the present invention. Examples of such software include, but are not limited to, MacPattern (EMBL), BLASTIN, and BLASTIX (NCBIA). One of the available algorithms or implementing software packages for conducting homology searches can be adapted for use in the present computer-based systems.  
           [0207]    The most preferred sequence length of a target sequence is from about 10 to 100 amino acids or from about 30 to 300 nucleotide residues. However, it is well recognized that during searches for commercially important fragments of the nucleic acid molecules of the present invention, such as sequence fragments involved in gene expression and protein processing, the target sequence may be of shorter length.  
           [0208]    As used herein, “a target structural motif,” or “target motif” refers to any rationally selected sequence or combination of sequences in which the sequences are chosen based on a three-dimensional configuration which is formed upon the folding of the target motif. There are a variety of target motifs known in the art. Protein target motifs include, but are not limited to, enzymatic active sites and signal sequences. Nucleic acid target motifs include, but are not limited to, promoter sequences, cis elements, hairpin structures, and inducible expression elements (protein binding sequences).  
           [0209]    Thus, the present invention further provides an input means for receiving a target sequence, a data storage means for storing the target sequences of the present invention sequence identified using a search means as described above, and an output means for outputting the identified homologous sequences. A variety of structural formats for the input and output means can be used to input and output information in the computer-based systems of the present invention. A preferred format for an output means ranks fragments of the sequence of the present invention by varying degrees of homology to the target sequence or target motif. Such presentation provides a skilled artisan with a ranking of sequences which contain various amounts of the target sequence or target motif and identifies the degree of homology contained in the identified fragment.  
           [0210]    A variety of comparing means can be used to compare a target sequence or target motif with the data storage means to identify sequence fragments sequence of the present invention. For example, implementing software that implement the BLAST and BLAZE algorithms (Altschul et al.,  J. Mol. Biol.  215:403-410 (1990)) can be used to identify non-coding regions within the nucleic acid molecules of the present invention. A skilled artisan can readily recognize that any one of the publicly available homology search programs can be used as the search means for the computer-based systems of the present invention.  
           [0211]    The following examples are illustrative and not intended to be limiting in any way. 
       
    
    
     EXAMPLES  
     Example 1  
       [0212]    Cloning of Desaturase Genomic Sequences  
         [0213]    1A. Soybean Δ12 Desaturase (FAD2-1)  
         [0214]    A soybean FAD2-1A sequence is identified by screening a soybean genomic library using a soybean FAD2-1 cDNA probe. Three putative soy FAD2-1 clones are identified and plaque purified. Two of the three soy FAD2-1 clones are ligated into pBluescript II KS+ (Stratagene) and sequenced. Both clones (14-1 and 11-12) are the same and match the soy FAD2-1 cDNA exactly. A sequence of the entire FAD2-1A clone is provided in SEQ ID NO:15.  
         [0215]    Prior to obtaining a full length clone, a portion of the FAD2-1A genomic clone is PCR amplified using PCR primers designed from the 5′ untranslated sequence (Primer 12506, 5′-ATACAA GCCACTAGGCAT-3′, SEQ ID NO:16) and within the cDNA (Primer 11698: 5′-GATTGGCCATGCAATGAGGGAAAAGG-3′, SEQ ID NO:17). The resulting PCR product is cloned into the vector pCR 2.1 (Invitrogen) and sequenced. A soy FAD2-1A partial genomic clone (SEQ ID NO:18) with an intron region (SEQ ID NO:1) is identified by comparison to the soybean cDNA sequence using the Pustell comparison program in Macvector. The FAD2-1A intron sequence (SEQ ID NO:1) begins after the ATG start codon, and is 420 bases long.  
         [0216]    A second FAD2-1 gene family member is also identified and cloned, and is referred to herein as FAD2-1B. The soy FAD2-1B partial genomic clone (SEQ ID NO:19) has a coding region (base pairs 1783-1785 and 2191-2463) and an intron region (base pairs 1786-2190) which are identified by comparison to the soybean cDNA sequence using the Pustell comparison program in Macvector. The FAD2-1B intron sequence (SEQ ID NO:2) begins after the ATG start codon and is 405 bases long. Other regions in the FAD2-1B partial genomic clone (SEQ ID NO:19) include a promoter (base pairs 1-1704) (SEQ ID NO:22) and 5′UTR (base pairs 1705-1782).  
         [0217]    1B. Soybean Δ15 Desaturase (FAD3)  
         [0218]    A partial soybean FAD3-1A genomic sequence is PCR amplified from soybean DNA using primers 10632, 5′-CUACUACUACUACTCGAGACAAAGCCTTTAGCCTATG-3′ (SEQ ID NO:20), and 10633: 5′-CAUCAUCAUCAUGGATCCCATGTCTCTCTATGCAAG-3′ (SEQ ID NO:21). The Expand Long Template PCR system (Boehringer Mannheim) is used according to the manufacturer&#39;s directions. The resulting PCR products are cloned into the vector pCR 2.1 (Invitrogen) and sequenced. A soy FAD3-1A partial genomic clone sequence (SEQ ID NO:23) and intron regions are confirmed by comparisons to the soybean FAD3-1A cDNA sequence using the Pustell program in Macvector.  
         [0219]    From the identified partial genomic soybean FAD3-1A sequence (SEQ ID NO:23), seven introns are identified: FAD3-1A intron #1(SEQ ID NO:5), FAD3-1A intron #2 (SEQ ID NO:6), FAD3-1A intron #3A (SEQ ID NO:7), FAD3-1A intron #4 (SEQ ID NO:8), FAD3-1A intron #5 (SEQ ID NO:9), FAD3-1A intron #3B (SEQ ID NO:10), and FAD3-1A intron #3C (SEQ ID NO:11). FAD3-1A Intron #1 is 192 base pairs long and is located between positions 294 and 485, FAD3-1A intron #2 is 348 base pairs long and is located between positions 576 and 923, FAD3-1A intron #3A is 142 base pairs long and is located between positions 991 and 1132, FAD3-1A intron #3B is 98 base pairs long and is located between positions 1225 and 1322, FAD3-1A intron #3C is 115 base pairs long and is located between positions 1509 and 1623, FAD3-1A intron #4 is 1231 base pairs long and is located between positions 1705 and 2935, and FAD3-1A intron #5 is 626 base pairs long and is located between positions 3074 and 3699.  
       Example 2  
       [0220]    Expression constructs  
         [0221]    The FAD2-1A intron sequence (SEQ ID NO:1) is amplified via PCR using the FAD2-1A partial genomic clone (SEQ ID NO:18) as a template and primers 12701(5′-ACGAATTCCTCGAGGTAAA TTAAATTGTGCCTGC-3′ (SEQ ID NO:24)) and 12702 (5′-GCGAGATCTATCG ATCTGTGTCAAAGTATAAAC-3′ (SEQ ID NO:25)). The resulting amplification products are cloned into the vector pCR 2.1 (Invitrogen) and sequenced. The FAD2-1A intron is then cloned into the expression cassette, pCGN3892, in sense and antisense orientations. The vector pCGN3892 contains the soybean 7S promoter and a pea RBCS 3′. Both gene fusions are then separately ligated into pCGN9372, a vector that contains the CP4 gene regulated by the FMV promoter. The resulting expression constructs (pCGN5469 sense and pCGN5471 antisense) are used for transformation of soybean using biolistic methods described below.  
         [0222]    The FAD2-1B intron sequence (SEQ ID NO:2) is amplified via PCR using the FAD2-1B partial genomic clone (SEQ ID NO:19) as a template and primers 13883 (5′-GCGATCGATGTATGATGCTAAATTAAATTGTGCCTG-3′ (SEQ ID NO:28)) and 13876 (5′-GCGGAATTCCTGTGTCAAAGTATAAAGAAG-3′ (SEQ ID NO:29)). The resulting amplification products are cloned into the vector pCR 2.1 (Invitrogen) and sequenced. The FAD2-1B intron is fused to the 3′ end of the FAD2-1A intron in plasmids pCGN5468 (contains the soybean 7S promoter fused to the FAD2-1A intron (sense) and a pea RBCS 3′) or pCGN5470 (contains the soybean 7S promoter fused to the FAD2-1A intron (antisense) and a pea RBCS 3′) in sense or antisense orientation respectively. The resulting intron combo fusions are then ligated separately into pCGN9372, a vector that contains the CP4 gene regulated by the FMV promoter. The resulting expression constructs (pCGN5485, FAD2-1A &amp; FAD2-1B intron sense and pCGN5486, FAD2-1A &amp; FAD2-1B intron antisense) are used for transformation of soybean using biolistic methods described below.  
         [0223]    Four of the seven introns identified from the soybean FAD3-1A genomic clone are PCR amplified using the FAD3-1A partial genomic clone as template and primers as follows: FAD3-1A Intron #1, primers 12568: 5′-GATCGATGCCCGGGGTAATAATTTTTGTGT-3′ (SEQ ID NO:30) and 12569: 5′-CACGCCTCGAGTGTTCAATTCAATCAATG-3′ (SEQ ID NO:31); FAD3-1A Intron #2, primers 12514: 5′-CACTCGAGTTAGTTCATACTGGCT-3′ (SEQ ID NO:32) and 12515: 5′-CGCATCGATTGCAAAATCCATCAAA-3′ (SEQ ID NO:33); FAD3-1A Intron #4, primers 10926: 5′-CUACUACUACUACTCGAGCGTAAATAGTGGGTGAACAC-3′ (SEQ ID NO:34) and 10927:5′-CAUCAUCAUCAUCTCGAGGAATTCGTCCATTTTAGTACACC-3′ (SEQ ID NO:35); FAD3-1A Intron #5, primers 10928: 5′-CUACUACUACUACTCGAGGCGCGT ACATTTTATTGCTTA-3′ (SEQ ID NO:36) and 10929: 5′-CAUCAUCAUCAUCT CGAGGAATTCTGCAGTGAATCCAAATG-3′ (SEQ ID NO:37). The resulting PCR products for each intron are cloned into the vector pCR 2.1 (Invitrogen) and sequenced.  
         [0224]    FAD3-1A introns #1, #2, #4 and #5 are all ligated separately into the pCGN3892, in sense or antisense orientations. pCGN3892 contains the soybean 7S promoter and a pea RBCS 3′. These fusions are ligated into pCGN9372, a vector that contains the CP4 gene regulated by the FMV promoter for transformation into soybean. The resulting expression constructs (pCGN5455, FAD3-1A intron #4 sense; pCGN5459, FAD3-1A intron #4 antisense; pCGN5456, FAD3 intron #5 sense; pCGN5460, FAD3-1A intron #5 antisense; pCGN5466, FAD3-1A intron #2 antisense; pCGN5473, FAD3-1A intron #1 antisense) are used for transformation of soybean using biolistic methods described below.  
         [0225]    Introns #3C and #4 are also PCR amplified from a second FAD3 gene family member (FAD3-1B). Soybean FAD3-1B introns #3C and #4 are PCR amplified from soybean DNA using the following primers, 5′CATGCTTTCTGTGCTTCTC 3′ (SEQ ID NO:26) and 5′GTTGATCCAACCATAGTCG 3′ (SEQ ID NO:27). The PCR products are cloned into the vector pCR 2.1 (Invitrogen) and sequenced. A sequence for the FAD3-1B introns #3C and #4 is provided in SEQ ID NOs:12 and 13, respectively.  
       Example 3  
       [0226]    Plant Transformation and Analysis  
         [0227]    Linear DNA fragments containing the expression constructs for sense and antisense expression of the Δ12 and Δ15 desaturase introns are stably introduced into soybean (Asgrow variety A4922) by the method of McCabe et al. (1988),  Bio/Technology,  6:923-926. Transformed soybean plants are identified by selection on media containing glyphosate.  
         [0228]    Fatty acid compositions are analyzed from seed of soybean lines transformed with the intron expression constructs using gas chromatography. R1 pooled seed and R1 single seed oil compositions demonstrate that the mono- and polyunsaturated fatty acid, compositions were altered in the oil of seeds from transgenic soybean lines as compared to that of the seed from non-transformed soybean. Table I provides a summary of results which were obtained using the described constructs. These data clearly show that sense and antisense expression of the non-coding regions of the desaturase gene results in the modification of the fatty acid compositions. The data also shows that introns can be used to obtain a variety of lines with varying fatty acid compositions. Selections can be made from such lines depending on the desired relative fatty acid composition. In addition, since each of the introns is able to modify the levels of each fatty acid to varying extends, it is contemplated that combinations of introns can be used depending on the desired compositions.  
                                                             TABLE I                       FAD2   Orientation   Event   Oleic   Linoleic   Linolenic                                wildtype (control)       5469-5 null R1 pool   18.15%   55.59%   7.97%               10 seed average   13.89%   55.89%    9.067%               5469-27 null R1 pool   19.15%   54.62%   9.32%               A4922   15.75%   56.1%    8.75%               5471-13 null R1 pool   17.02%   56.49%   9.08%               10 seed average   13.86%   56.14%   9.49%               A4922   14.95%   55.95%   9.07%       full length cDNA   sense   5462-133 R1 pool   84%    2.17%   1.55%       (control)       best 5462-133 R1 seed   84%   0.59%   1.76%       intron 1   sense   5469-6 R1 pool   29.93%   46.53%               5469-8 R1 pool   36.5%    42.11%   5.98%               best 5469-6 R1 seed   44.41%   29.34%   6.68%               best 5469-8 R1 seed   41.26%   33.16%   5.74%               5469-14 R1 pool   61.06%   16.42%   7.75%               5469-20 R1 pool   48.89%   31.61%   4.89%               5469-22 R1 pool   80%   2.97%   4.78%               best 5469-14 R1 seed   62.21%   11.97%   8.81%               5485-3 R1 pool   63.54%   14.09%   7.32%               5485-53 R1 pool   47.58%   27.64%   7.81%           antisense   5471-8 R1 pool   31.05%   43.62%   7.07%               5471-2 R1 pool   27.98%   48.88%   6.83%               5471-26 R1 pool   32.66%   44.54%   6.76%               best 5471-8 R1 seed   57.4%    23.37%   5.73%               best 5471-2 R1 seed   28.08%   46.14%   6.52%               best 5471-26 R1 seed   43.3%    34.15%   5.6%               5486-33 R1 pool   32.37%   43.66%   6.87%               5486-12 R1 pool   27.32%   46.97%   6.4%                5486-40 R1 pool   26.79%   48.72%   6.55%       FAD3       wildtype (control)       5473-7 null R1 pool   15.65%   56.74%   9.55%               A4922 R1 pool   19.84%   56.79%   7.48%       full length cDNA   sense   5464-50 R1 pool   18.06%   62.03%   2.75%       (control)       best 5464-50 R1 seed   17.08%   62.44%   1.72%       intron 1   antisense   5473-8 R1 pool   33.47%   45.97%   5.54%               5473-1 R1 pool   33.34%   42.67%   7.59%       intron 2   antisense   5466-20 R1 pool   28.43%   48.83%   6.37%               5466-16 R1 pool   27.61%   49.92%   5.96%       intron 4   sense   5455-19 R1 pool   40.35%   39.97%   4.61%               5455-10 R1 pool   35.14%   43.59%   5.53%               5455-57 R1 pool   38.04%   42.44%   5.24%               5455-76 R1 pool   37.24%   42.42%   5.37%               5455-107 R1 pool   36.44%   42.72%   5.62%               best 5455-57 R1 seed   45.36%   35.55%   4.92%               best 5455-76 R1 seed   35.3%    43.54%   5.53%               best 5455-107 R1 seed   45.56%   34.85%   5.12%           antisense   5459-2 R1 pool   34.5%    43.87%   5.59%               5459-6 R1 pool   33.78%   44.12%   5.62%               5459-20 R1 pool   28.26%   49.48%   5.5%               best 5459-2 R1 seed   61.45%   23.45%   3.38%               best 5459-6 R1 seed   53.51%   29.68%   3.53%               best 5459-20 R1 seed   30%   50.55%   4.15%       intron 5   sense   5456-38 R1 pool   28.23%   49.59%   6.74%               5456-62 R1 pool   28.94%   48.66%   6.25%               best 5456-62 R1 seed   29.5%   43.69%   5.4%            antisense   5460-9 R1 pool   29.78%   48.57%   5.54%               5460-21 R1 pool   28.37%   49.79%   5.54%               best 5460-21 R1 seed   35.18%   40.52%   5.33%                  
 
       Example 4  
       [0229]    RNA is isolated from homozygous R2 seed from two FAD2-1 intron suppressed lines (5469-14 and 5469-22), from two FAD2-1 cDNA suppressed lines (positive controls) (5462-87 and 5462-133), and from negative controls (wild type seed and seed from null segregants from each intron suppressed event). Northern gels containing these RNA samples are probed with the FAD2-1 cDNA. FAD2-1A transcript levels are significantly reduced in both the intron suppressed lines and the cDNA suppressed lines relative to the negative controls. The same Northern blot is probed with the constitutive FAD2-2 cDNA and no significant differences in the FAD2-2 transcript levels are observed between the FAD2-1 intron suppressed lines and the controls. In contrast, the FAD2-2 transcript in the cDNA suppressed lines, is significantly reduced. This Northern data indicates that the FAD2-1A intron is specifically inhibiting the accumulation of the FAD2-1 transcript but not the FAD2-2 transcript. A partial FAD2-2 genomic clone (SEQ ID NO:3) is PCR amplified and sequence analysis reveals a 4.7 KB intron in the 5′ untranslated region of the gene. The sequence of the FAD2-2 intron (SEQ ID NO:4) shares no homology with the FAD2-1 intron.  
       Example 5  
       [0230]    Southern blot data indicated that there are at least two FAD3 gene family members. To determine the sequence of the other FAD3 gene family member and to determine if other members existed, a FAD3-1A gene sequence is used for a query Blast search against the soybean DNA sequences. Candidate ESTs from different FAD3 gene family members are used to design primers. Using this strategy, 2 primer sets are designed based on putative FAD3 sequences. Intron #4 regions from two other FAD3 gene family members are isolated. Primers are designed from the 211565 — 1.r1040 EST (designated FAD3-1B), (5′ primer #15024: 5′-CATGCTTTCTGTGCTTCTC-3′ (SEQ ID NO:26) and 3′ primer #15027: 5′-GTTGATCCAACCATAGTCG-3′ (SEQ ID NO:27)) in the region corresponding to the position of intron #4 of the FAD3-1A gene. These primers are used to PCR amplify the FAD3-1B intron #4 (SEQ ID NO:13), which when sequenced shared no sequence homology with the FAD3-1A intron #4 (SEQ ID NO:8). The FAD3-1B gene also contains an intron #3C (SEQ ID NO:12), which also did not share any homology with the FAD3-1A intron #3C (SEQ ID NO:11).  
         [0231]    Another additional intron #4 is PCR amplified from a second EST, gsv701051989.H1 (designated FAD3-1C) using the following set of primers: 5′ primer #16241: 5′-CACCATGGTCATCATCAGAAAC (SEQ ID NO:38) and the 3′ primer #16242: TCACGATCCACAGTTGTGAGAC (SEQ ID NO:39). The FAD3-1C intron #4 (SEQ ID NO:14) shares 50% homology with the FAD3-1A intron #4 (SEQ ID NO:8) and shares no homology with the FAD3-1B intron #4 (SEQ ID NO:13). The FAD3-1C EST, like the FAD3-1B EST, also contains an intron #4 splice site in the same region of the gene.  
       Example 6  
       [0232]    Fad2-1A/Fad3-1A Transformed Plants  
         [0233]    A soybean FAD2-1A intron suppressed line can be used to pollinate a soybean FAD3-1A intron suppressed line generated according to the methodology set forth in Example 3. RNA from soybean seeds containing both an expressed FAD2-1A intron region and FAD3-1A intron region can be screened using Northern blots (as described in Example 4) to determine the levels of FAD2-1, FAD2-2, FAD3-1A and FAD3-1B transcripts. Soybean plants with undetectable or low levels of FAD2-1 and FAD3-1A transcripts can be screened for fatty acid composition as set forth in Example 3.  
       Example 7  
       [0234]    Single Fad2/Fad3 Constructs  
         [0235]    Linear DNA fragments containing sense and antisense FAD2 and FAD3 introns, as well as FAD2 and FAD3 introns capable of producing a dsRNA, can be constructed as set forth in Table II.  
                                                     TABLE II                               Structural Nucleic       Structural Nucleic               Acid 1       Acid 2               (sense, antisense,       (sense, antisense,       Construct No.   Promoter 1   dsRNA)   Promotor 2   dsRNA)                                1   CaMV   FAD2-1A intron 1   CaMV   FAD3-1A intron 1       2   CaMV   FAD2-1B intron 1   CaMV   FAD3-1A intron 1       3   CaMV   FAD2-1A intron 1   CaMV   FAD3-1A intron 4       4   CaMV   FAD2-1B intron 1   CaMV   FAD3-1A intron 4       5   CaMV   FAD2-1A intron 1   CaMV   FAD3-1B intron 4       6   CaMV   FAD2-1B intron 1   CaMV   FAD3-1B intron 4       7   CaMV   FAD2-1A intron 1   CaMV   FAD3-1C intron 4       8   CaMV   FAD2-1B intron 1   CaMV   FAD3-1C intron 4       9   CaMV   FAD2-1A intron 1   CaMV   FAD2-2B intron 1       10   CaMV   FAD2-1B intron 1   CaMV   FAD2-2B intron 1       11   napin   FAD2-1A intron 1   napin   FAD3-1A intron 1       12   napin   FAD2-1B intron 1   napin   FAD3-1A intron 1       13   napin   FAD2-1A intron 1   napin   FAD3-1A intron 4       14   napin   FAD2-1B intron 1   napin   FAD3-1A intron 4       15   napin   FAD2-1A intron 1   napin   FAD3-1B intron 4       16   napin   FAD2-1B intron 1   napin   FAD3-1B intron 4       17   napin   FAD2-1A intron 1   napin   FAD3-1C intron 4       18   napin   FAD2-1B intron 1   napin   FAD3-1C intron 4       19   napin   FAD2-1A intron 1   napin   FAD2-2B intron 1       20   napin   FAD2-1B intron 1   napin   FAD2-2B intron 1       21   7S   FAD2-1A intron 1   CaMV   FAD3-1A intron 1       22   7S   FAD2-1B intron 1   CaMV   FAD3-1A intron 1       23   7S   FAD2-1A intron 1   CaMV   FAD3-1A intron 4       24   7S   FAD2-1B intron 1   CaMV   FAD3-1A intron 4       25   7S   FAD2-1A intron 1   CaMV   FAD3-1B intron 4       26   7S   FAD2-1B intron 1   CaMV   FAD3-1B intron 4       27   7S   FAD2-1A intron 1   CaMV   FAD3-1C intron 4       28   7S   FAD2-1B intron 1   CaMV   FAD3-1C intron 4       29   7S   FAD2-1A intron 1   CaMV   FAD2-2B intron 1       30   7S   FAD2-1B intron 1   CaMV   FAD2-2B intron 1       31   CaMV   FAD2-1A intron 1   7S   FAD3-1A intron 1       32   CaMV   FAD2-1B intron 1   7S   FAD3-1A intron 1       33   CaMV   FAD2-1A intron 1   7S   FAD3-1A intron 4       34   CaMV   FAD2-1B intron 1   7S   FAD3-1A intron 4       35   CaMV   FAD2-1A intron 1   7S   FAD3-1B intron 4       36   CaMV   FAD2-1B intron 1   7S   FAD3-1B intron 4       37   CaMV   FAD2-1A intron 1   7S   FAD3-1C intron 4       38   CaMV   FAD2-1B intron 1   7S   FAD3-1C intron 4       39   CaMV   FAD2-1A intron 1   7S   FAD2-2B intron 1       40   CaMV   FAD2-1B intron 1   7S   FAD2-2B intron 1                  
 
         [0236]    As shown, each construct listed in the table can have several configurations depending on the nature and orientation of the structural nucleic acids in the construct. For example, construct 30 may be configured as follows: (1) 7S promoter—FAD2-1B intron 1 (sense)—CaMV promoter—FAD2-2B intron 1(sense); (2) 7S promoter—FAD2-1B intron 1 (sense)—CaMV promoter—FAD2-2B intron 1 (antisense); (3) 7S promoter—FAD2-1B intron 1 (sense)—CaMV promoter—FAD2-2B intron 1 (dsRNA); (4) 7S promoter—FAD2-1B intron 1 (antisense)—CaMV promoter—FAD2-2B intron 1 (sense); (5) 7S promoter—FAD2-1B intron 1 (antisense)—CaMV promoter—FAD2-2B intron 1 (antisense); (6) 7S promoter—FAD2-1B intron 1 (antisense)—CaMV promoter—FAD2-2B intron 1 (dsRNA); (7) 7S promoter—FAD2-1B intron 1 (dsRNA)—CaMV promoter—FAD2-2B intron 1 (sense); (8) 7S promoter—FAD2-1B intron 1 (dsRNA)—CaMV promoter—FAD2-2B intron 1 (antisense); or (9) 7S promoter—FAD2-1B intron 1 (dsRNA)—CaMV promoter—FAD2-2B intron 1 (dsRNA).  
         [0237]    These constructs can be stably introduced into soybean (for example, Asgrow variety A4922 or Asgrow variety A3244) by the methods described earlier, including the methods of McCabe et al. (1988),  Bio/Technology,  6:923-926 or Agrobacterium-mediated transformation. Transformed soybean plants are identified by selection on media containing glyphosate. Fatty acid compositions are analyzed from seed of soybean lines transformed with the constructs using gas chromatography.  
       Example 8  
       [0238]    Linear DNA fragments containing expression constructs for sense and antisense expression of the FAD2-1 and FAD2-2 introns are stably introduced into soybean (Asgrow variety A4922) by the method of McCabe et al. (1988),  Bio/Technology,  6:923-926. The following constructs are introduced: (1) FAD2-1A intron (sense)—FAD2-2 intron (antisense); (2) FAD2-1A intron (sense)—FAD2-2 intron (sense); (3) FAD2-1A intron (antisense)—FAD2-2 intron (antisense); (4) FAD2-1A intron (antisense)—FAD2-2 intron (sense); (5) FAD2-1B intron (sense)—FAD2-2 intron (antisense); (6) FAD2-1B intron (sense)—FAD2-2 intron (sense); (7) FAD2-1B intron (antisense)—FAD2-2 intron (antisense); and (8) FAD2-1B intron (antisense)—FAD2-2 intron (sense). Transformed soybean plants are identified by selection on media containing glyphosate. Fatty acid compositions are analyzed from seed of soybean lines transformed with the constructs using gas chromatography. Seed of the transformed plants exhibit high levels of oleic acid (over 80%).  
         [0239]    Additional linear DNA fragments containing expression constructs for sense and antisense expression of the FAD2-1, FAD2-2, and FAD3 introns are stably introduced into soybean (Asgrow variety A4922) by the method of McCabe et al. (1988),  Bio/Technology,  6:923-926. Exemplary constructs include: (1) FAD2-1A intron (sense or antisense)—FAD2-2 intron (sense or antisense)—FAD3-1A intron 1 (sense or antisense); (2) FAD2-1A intron (sense or antisense)—FAD2-2 intron (sense or antisense)—FAD3-1A intron 4 (sense or antisense); (3) FAD2-1A intron (sense or antisense)—FAD2-2 intron (sense or antisense)—FAD3-1B intron 4 (sense or antisense); and (4) FAD2-1A intron (sense or antisense)—FAD2-2 intron (sense or antisense)—FAD3-1C intron 4 (sense or antisense). Transformed soybean plants are identified by selection on media containing glyphosate. Fatty acid compositions are analyzed from seed of soybean lines transformed with the constructs using gas chromatography. Seed of the transformed plants exhibit high levels of oleic acid (over 80%).  
         [0240]    All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.  
     
       
       
         1 
         
           
             39  
           
           
             1  
             420  
             DNA  
             Glycine max  
           
            1 

gtaaattaaa ttgtgcctgc acctcgggat atttcatgtg gggttcatca tatttgttga     60 

ggaaaagaaa ctcccgaaat tgaattatgc atttatatat cctttttcat ttctagattt    120 

cctgaaggct taggtgtagg cacctagcta gtagctacaa tatcagcact tctctctatt    180 

gataaacaat tggctgtaat gccgcagtag aggacgatca caacatttcg tgctggttac    240 

tttttgtttt atggtcatga tttcactctc tctaatctct ccattcattt tgtagttgtc    300 

attatcttta gatttttcac tacctggttt aaaattgagg gattgtagtt ctgttggtac    360 

atattacaca ttcagcaaaa caactgaaac tcaactgaac ttgtttatac tttgacacag    420 

 
           
             2  
             405  
             DNA  
             Glycine max  
           
            2 

gtatgatgct aaattaaatt gtgcctgcac cccaggatat ttcatgtggg attcatcatt     60 

tattgaggaa aactctccaa attgaatcgt gcatttatat tttttttcca tttctagatt    120 

tcttgaaggc ttatggtata ggcacctaca attatcagca cttctctcta ttgataaaca    180 

attggctgta ataccacagt agagaacgat cacaacattt tgtgctggtt accttttgtt    240 

ttatggtcat gatttcactc tctctaatct gtcacttccc tccattcatt ttgtacttct    300 

catatttttc acttcctggt tgaaaattgt agttctcttg gtacatacta gtattagaca    360 

ttcagcaaca acaactgaac tgaacttctt tatactttga cacag                    405 

 
           
             3  
             6220  
             DNA  
             Glycine max  
           
            3 

agcttggtac cgagctcgga tccactagta acggccgcca gtgtgctgga attcggcttc     60 

tctctcaccc tcctcttcac acattttctg tgcgctctaa caaacattct cgttcacact    120 

ttcaggtact tttctctcct tatctcttta tctttattct ttcctacttt attgcttaaa    180 

ccaatgctat ctatgcttcg atctcgcctt cttattttcc acttcccttt tctcgcttga    240 

tctaaccgtt ttcgccctcc gcgcttcgat tgactgagta catctacgat tctctgttct    300 

ttcatttcat agatttcgtc tgattttggc taacttggtt tctgttgcgg ccgattctta    360 

catatactga ttgtttagca taaatgaact tgcttgttta gcactatctg catattttcg    420 

tcacgcatct ctttcggatc taaggatgaa tctcctattt cctccgtatt atttctcgta    480 

tctcttgttc tgtgctaatg ctccagaaaa tggcagcatt gtcttcttct ttgctgtata    540 

agtgtttgtg ttgtgaatct ggaagcgatt ttgcgtgagg taacttgcga cttcaactat    600 

tatctttcag atctcgttaa tttattagct gctattaatt tgtgtgtgca gtgtcaaact    660 

gaagcacacg actgcttaga agttagaatt tgactgactg ttcctctttg atttttttct    720 

ttcttttctt tgctwactcg gcctatttaa tgatctttat aaatagatta gtggaccact    780 

tggttagttg gtgagttatg aatattcgaa ttttctacca caagttgggt taaaaaaatc    840 

tctgcaacta cacgaggatt ttttatttta tttagaggaa actattctgt catccttttt    900 

ccgattacac ttttctatca gttgttttga aatatacacc ttaggaatat aatattaccc    960 

ctttcggtct taatataaat atattttaat tatttatatt ttatttaatg aaattatttt   1020 

taaaatactt tcatttaata gaatttttaa taaagttaaa gacttttatt gtgtagagtt   1080 

taacgaagtt aattagtttt cttagtaaat gtaaaatatg ccttttttgt tgtttataat   1140 

ggagattgga aaaaatatac tttaattttt ttcaagtgat gaataattat ggatgttttg   1200 

tcaatatttt tgtcttgcta tacaactttc agtcttgcca ttaaataatt ttgaatgtgt   1260 

tattgatatc tctgaacaat atttagagac gaacataaat tttatatatt ttatataatt   1320 

tctttttatt acccttttat tatcaatttt gaaatttggt taatatctgt gtttcatttt   1380 

gaggtctcaa atttgatata aggaggttca aaatgcgttg ctagccattt taaagattag   1440 

caggagagga aatgtttctg gacttaaatt taaaatatgc ttatttgttt ttcaagagag   1500 

agagatcaat atttatataa tacacttgaa ttaatataca ccattgttgc aaaaaaaaaa   1560 

aaatattagt tgattgtgtg acaatatttt atattaaata taattagtta atttagttca   1620 

agttgagtta catttttaca taccattctt agccgccact tttttatatt tatttgtagg   1680 

aataactttt catctgtatc aattttcccc gtctaataaa aagggtttga ctttttctta   1740 

taatagagtt tttttttttt tgctttaagt tattgtaaaa taattatttt attttttttg   1800 

cctttgtaaa ttatgtatat ttaatgtttt aataggaaaa aaatgttatc aaaagcacta   1860 

aaagactaaa attaaacaac cataatttgc aaagatgaaa ataaaaaaat aattttgtaa   1920 

agataaaaaa tgaaataaaa tagttaaatt ataggaattt aaaagctatt taaatcaaca   1980 

aaagttaaag tttctgtaaa aaaagttcaa tttttttttt tattattgaa aaagttaaag   2040 

ctaatgagcg ttcgatttgg gttagtatgt agtatttatt attttcaaga ttttggattt   2100 

tattgtcgat gtttctgatt tgaatataat tattttccat tcaacttgtg attttataag   2160 

aaaaaaaaag gtacagaaaa aatcaagcgc tttttttatt tcaattagtg gaggtttcac   2220 

tgaaatgggt aaagaatcta ttttgcaatc acaattatta ccggtattca actgcaacaa   2280 

ggaacaaaat tcctttcgta aatatacgga gaggaatcta ttttgacttg ttgaatttat   2340 

ggtaaagtag aatttagaat ttaattatga gttgaagtaa ttttgaataa tttatatgtt   2400 

aaatataaaa ttttgtacta agttttattc ataactttga ttctataata caaacataca   2460 

taagttcaaa aataatttta attaaaatta attttatcaa tttttattca aacacgagtc   2520 

taatttgctt gatgaattaa gaaaataagg aagaaaatat taaaaactag gagagaagtt   2580 

aaagagaatt tcatctttat tattctcagt tgtttcaaaa ataatgaaag gatagctata   2640 

taatactgta actgagccaa gaacatattt gccgtccgag taaccttttc ttttcttgtt   2700 

ccgttttctc cgccgatgaa gagagggaag ggaatgtatc tttgtattta tgttttcaaa   2760 

gagttcgtgc ataaaattgg tttaatcaaa tttttcataa gattattatt ttatgatttt   2820 

ttaaaataaa ttagtaacta tattccgtaa gtcgtacaca gttatatgta gtaagtaaat   2880 

tatattttaa taattattat cttaaaattt tcttaagaac ttggttaaaa tatttttgtt   2940 

tgaaaaagtt tatgataact tttttttgtt gaaaaaaagt ttacgattat ctaactcgta   3000 

cttagattat ttctaattgg gatttattga agggtttttt aagtaaagaa attgtttctt   3060 

atggtttctt ttttattgga caaatttacg tagcaaagag tgtttcttaa aaacaagaca   3120 

tgtatccttt gaaaaaaaac tatttctttg aaataaaaaa taatatttat ctggcacata   3180 

ataatgttaa aattaaatca taattaggta aaaataaaat aaatataaaa gtatgagttt   3240 

gttaagtttt ttataatttt ttattattaa agtaaaatta tgtatgattt ttttataatg   3300 

atatgatatt ttagggatca caaaaaataa tgtggtgaat acaaaagtaa ctcaaaaaat   3360 

tcatttagta aattttcatt ggagatgcta ttattatgct ttctgattgc tttgtccaaa   3420 

aaataaagaa tgttttttta tttgaaaatt gaaaatttct gggtcatgtt aagatcttgt   3480 

agacggtaac gtcggcctaa agttgtgtga ggggtgttgc atgcaccgat cattaattac   3540 

tcgatatgga aaacgactga aataatttaa tttgatgttg ctaatattgg ccatccctct   3600 

catcattatt gtttttttat ttgtaacatg acatattctt gtgggtccgc tacggattgg   3660 

gtgtttgttg ccaaaaaata caaaatatct gtggaacaag gataaacagt cttgtttgtt   3720 

taattgattg attgatgagt ttgcaagcta tatttttaat ttattttaat taaacttttg   3780 

tgttttagtt ctacaatttt attcatcttg attttttttt tacttggcaa aatcatgatt   3840 

ttttaatttt tacttatgtt gaaaacaaat ttattgctaa aaaaacattt attctttttt   3900 

tagagaaaaa acaaatttgt gatatgtagt gaatcaaatg aaaattttaa acataatata   3960 

gaatactcta caaatcaatt ttgagtttct ttatcatttt atttatttat tgacatactt   4020 

ctactttctg caaagaccct gactcgtgga agatataggg aaggttatgg aagttagtgt   4080 

attgtcatat ctagctatct ttgctaattg aaaaagcctt ccctttgttt acagatctgg   4140 

ataaggttgc atgtttattc ttttcaactg tgaatggttc tttgcatctt ttttagtata   4200 

tgagattaat gttttaatta ggaagaagct tttagaacat cacccgaatc caattcgttt   4260 

tggtttctgt gatcttgatg taaatctata ctaatttggt ttgggcagaa gaaaatgttc   4320 

tttgctcaag tcctctagga cgaaaatata aatataacag ggtatatcag atctctattc   4380 

ttctgtgggt aatgatagca tgtttctgtt gttttcttat tcttcattgg tcatgataac   4440 

ctgctaattc tatttgccac gattgagatg aaaaggtaat gaactagtaa acaataatga   4500 

gaagaatatg tcgctactat tgttgaaacg gttacgccag gcacttgagt atgatgcact   4560 

attttaatta atgcattttt tttgctttga tgagaacgca cattgttcat tctgattcgg   4620 

tgagtttaga aactattgct gataatcctt gatttaagat tttagtcttg ttcatgttca   4680 

ttaaaagtgt tgtaaaaaaa tgcactgata tgtcatgtgc agattgtgtg aagatggggg   4740 

cgggtggccg aactgatgtt cctcctgcca acaggaagtc agaggttgac cctttgaagc   4800 

gggtgccatt tgaaaaacct ccatttagtc tcagccaaat caagaaggtc attccacctc   4860 

actgtttcca gcgttctgtt ttccgctcat tctcctatgt tgtttacgac ctcaccatag   4920 

ccttctgcct ctattatgtt gccacccatt acttccacct ccttcccagc cctctctctt   4980 

tcttggcatg gccaatctac tgggctgtcc aaggttgcat ccttactgga gtttgggtca   5040 

ttgcccatga gtgtggccac catgcattca gtgactacca gttgcttgat gatattgttg   5100 

gccttgtcct ccactccggt ctcctagtcc catacttttc atggaaatac agccatcgcc   5160 

gtcaccactc caacactggt tctcttgagc gggatgaagt atttgtgcca aagcagaagt   5220 

cctgtatcaa gtggtactct aaatacctta acaatcctcc aggcagagtc ctcactcttg   5280 

ctgtcaccct cacacttggt tggcccttgt acttggcttt aaatgtttct ggaaggcctt   5340 

atgatagatt tgcttgccac tatgacccat atggtcccat ttactctgat cgtgaacgac   5400 

ttcaaatata tatatcagat gcaggagtac ttgcagtatg ctatggcctt ttccgtcttg   5460 

ccatggcaaa aggacttgcc tgggtggtgt gtgtttatgg agttccattg ctagtggtca   5520 

atggattttt ggtgttgatt acattcttgc agcatactca ccctgcattg ccacattaca   5580 

cttcctctga gtgggactgg ttgagaggag ctttagcaac agtggataga gattatggaa   5640 

tcctgaacaa ggtcttccat aatattacag acactcatgt agcacatcac ttgttctcca   5700 

caatgccaca ttatcatgca atggaggcta caaaggcaat aaaacccatt ttgggagagt   5760 

attatcggtt tgatgagact ccatttgtca aggcaatgtg gagagaggca agagagtgta   5820 

tttatgtgga gccagatcaa agtaccgaga gcaaaggtgt attttggtac aacaataagt   5880 

tgtgatgatt aatgtagccg aggcttcttt gaactttccc ttgtgactgt ttagtatcat   5940 

ggttgcttat tgggaataat tttgttgaac cctgatgttg gtagtaagta tctagacagt   6000 

tgcatagcgg ttttgtttac agaataagat atagcctctc tgaacagttt gattattgca   6060 

ccatggtttg caatcggtgc atgtcgacca agtttctcaa gactgtggag aagcttattc   6120 

ttgttccagt tcttgaatcc aagttgttac cgtattctgt aagccgaatt ctgcagatat   6180 

ccatcacact ggcggccgct cgagcatgca tctagagggc                         6220 

 
           
             4  
             4597  
             DNA  
             Glycine max  
           
            4 

gtacttttct ctccttatct ctttatcttt attctttcct actttattgc ttaaaccaat     60 

gctatctatg cttcgatctc gccttcttat tttccacttc ccttttctcg cttgatctaa    120 

ccgttttcgc cctccgcgct tcgattgact gagtacatct acgattctct gttctttcat    180 

ttcatagatt tcgtctgatt ttggctaact tggtttctgt tgcggccgat tcttacatat    240 

actgattgtt tagcataaat gaacttgctt gtttagcact atctgcatat tttcgtcacg    300 

catctctttc ggatctaagg atgaatctcc tatttcctcc gtattatttc tcgtatctct    360 

tgttctgtgc taatgctcca gaaaatggca gcattgtctt cttctttgct gtataagtgt    420 

ttgtgttgtg aatctggaag cgattttgcg tgaggtaact tgcgacttca actattatct    480 

ttcagatctc gttaatttat tagctgctat taatttgtgt gtgcagtgtc aaactgaagc    540 

acacgactgc ttagaagtta gaatttgact gactgttcct ctttgatttt tttctttctt    600 

ttctttgctw actcggccta tttaatgatc tttataaata gattagtgga ccacttggtt    660 

agttggtgag ttatgaatat tcgaattttc taccacaagt tgggttaaaa aaatctctgc    720 

aactacacga ggatttttta ttttatttag aggaaactat tctgtcatcc tttttccgat    780 

tacacttttc tatcagttgt tttgaaatat acaccttagg aatataatat tacccctttc    840 

ggtcttaata taaatatatt ttaattattt atattttatt taatgaaatt atttttaaaa    900 

tactttcatt taatagaatt tttaataaag ttaaagactt ttattgtgta gagtttaacg    960 

aagttaatta gttttcttag taaatgtaaa atatgccttt tttgttgttt ataatggaga   1020 

ttggaaaaaa tatactttaa tttttttcaa gtgatgaata attatggatg ttttgtcaat   1080 

atttttgtct tgctatacaa ctttcagtct tgccattaaa taattttgaa tgtgttattg   1140 

atatctctga acaatattta gagacgaaca taaattttat atattttata taatttcttt   1200 

ttattaccct tttattatca attttgaaat ttggttaata tctgtgtttc attttgaggt   1260 

ctcaaatttg atataaggag gttcaaaatg cgttgctagc cattttaaag attagcagga   1320 

gaggaaatgt ttctggactt aaatttaaaa tatgcttatt tgtttttcaa gagagagaga   1380 

tcaatattta tataatacac ttgaattaat atacaccatt gttgcaaaaa aaaaaaaata   1440 

ttagttgatt gtgtgacaat attttatatt aaatataatt agttaattta gttcaagttg   1500 

agttacattt ttacatacca ttcttagccg ccactttttt atatttattt gtaggaataa   1560 

cttttcatct gtatcaattt tccccgtcta ataaaaaggg tttgactttt tcttataata   1620 

gagttttttt ttttttgctt taagttattg taaaataatt attttatttt ttttgccttt   1680 

gtaaattatg tatatttaat gttttaatag gaaaaaaatg ttatcaaaag cactaaaaga   1740 

ctaaaattaa acaaccataa tttgcaaaga tgaaaataaa aaaataattt tgtaaagata   1800 

aaaaatgaaa taaaatagtt aaattatagg aatttaaaag ctatttaaat caacaaaagt   1860 

taaagtttct gtaaaaaaag ttcaattttt ttttttatta ttgaaaaagt taaagctaat   1920 

gagcgttcga tttgggttag tatgtagtat ttattatttt caagattttg gattttattg   1980 

tcgatgtttc tgatttgaat ataattattt tccattcaac ttgtgatttt ataagaaaaa   2040 

aaaaggtaca gaaaaaatca agcgcttttt ttatttcaat tagtggaggt ttcactgaaa   2100 

tgggtaaaga atctattttg caatcacaat tattaccggt attcaactgc aacaaggaac   2160 

aaaattcctt tcgtaaatat acggagagga atctattttg acttgttgaa tttatggtaa   2220 

agtagaattt agaatttaat tatgagttga agtaattttg aataatttat atgttaaata   2280 

taaaattttg tactaagttt tattcataac tttgattcta taatacaaac atacataagt   2340 

tcaaaaataa ttttaattaa aattaatttt atcaattttt attcaaacac gagtctaatt   2400 

tgcttgatga attaagaaaa taaggaagaa aatattaaaa actaggagag aagttaaaga   2460 

gaatttcatc tttattattc tcagttgttt caaaaataat gaaaggatag ctatataata   2520 

ctgtaactga gccaagaaca tatttgccgt ccgagtaacc ttttcttttc ttgttccgtt   2580 

ttctccgccg atgaagagag ggaagggaat gtatctttgt atttatgttt tcaaagagtt   2640 

cgtgcataaa attggtttaa tcaaattttt cataagatta ttattttatg attttttaaa   2700 

ataaattagt aactatattc cgtaagtcgt acacagttat atgtagtaag taaattatat   2760 

tttaataatt attatcttaa aattttctta agaacttggt taaaatattt ttgtttgaaa   2820 

aagtttatga taactttttt ttgttgaaaa aaagtttacg attatctaac tcgtacttag   2880 

attatttcta attgggattt attgaagggt tttttaagta aagaaattgt ttcttatggt   2940 

ttctttttta ttggacaaat ttacgtagca aagagtgttt cttaaaaaca agacatgtat   3000 

cctttgaaaa aaaactattt ctttgaaata aaaaataata tttatctggc acataataat   3060 

gttaaaatta aatcataatt aggtaaaaat aaaataaata taaaagtatg agtttgttaa   3120 

gttttttata attttttatt attaaagtaa aattatgtat gattttttta taatgatatg   3180 

atattttagg gatcacaaaa aataatgtgg tgaatacaaa agtaactcaa aaaattcatt   3240 

tagtaaattt tcattggaga tgctattatt atgctttctg attgctttgt ccaaaaaata   3300 

aagaatgttt ttttatttga aaattgaaaa tttctgggtc atgttaagat cttgtagacg   3360 

gtaacgtcgg cctaaagttg tgtgaggggt gttgcatgca ccgatcatta attactcgat   3420 

atggaaaacg actgaaataa tttaatttga tgttgctaat attggccatc cctctcatca   3480 

ttattgtttt tttatttgta acatgacata ttcttgtggg tccgctacgg attgggtgtt   3540 

tgttgccaaa aaatacaaaa tatctgtgga acaaggataa acagtcttgt ttgtttaatt   3600 

gattgattga tgagtttgca agctatattt ttaatttatt ttaattaaac ttttgtgttt   3660 

tagttctaca attttattca tcttgatttt ttttttactt ggcaaaatca tgatttttta   3720 

atttttactt atgttgaaaa caaatttatt gctaaaaaaa catttattct ttttttagag   3780 

aaaaaacaaa tttgtgatat gtagtgaatc aaatgaaaat tttaaacata atatagaata   3840 

ctctacaaat caattttgag tttctttatc attttattta tttattgaca tacttctact   3900 

ttctgcaaag accctgactc gtggaagata tagggaaggt tatggaagtt agtgtattgt   3960 

catatctagc tatctttgct aattgaaaaa gccttccctt tgtttacaga tctggataag   4020 

gttgcatgtt tattcttttc aactgtgaat ggttctttgc atctttttta gtatatgaga   4080 

ttaatgtttt aattaggaag aagcttttag aacatcaccc gaatccaatt cgttttggtt   4140 

tctgtgatct tgatgtaaat ctatactaat ttggtttggg cagaagaaaa tgttctttgc   4200 

tcaagtcctc taggacgaaa atataaatat aacagggtat atcagatctc tattcttctg   4260 

tgggtaatga tagcatgttt ctgttgtttt cttattcttc attggtcatg ataacctgct   4320 

aattctattt gccacgattg agatgaaaag gtaatgaact agtaaacaat aatgagaaga   4380 

atatgtcgct actattgttg aaacggttac gccaggcact tgagtatgat gcactatttt   4440 

aattaatgca ttttttttgc tttgatgaga acgcacattg ttcattctga ttcggtgagt   4500 

ttagaaacta ttgctgataa tccttgattt aagattttag tcttgttcat gttcattaaa   4560 

agtgttgtaa aaaaatgcac tgatatgtca tgtgcag                            4597 

 
           
             5  
             191  
             DNA  
             Glycine max  
           
            5 

gtaataattt ttgtgtttct tactcttttt tttttttttt tgtttatgat atgaatctca     60 

cacattgttc tgttatgtca tttcttcttc atttggcttt agacaactta aatttgagat    120 

ctttattatg tttttgctta tatggtaaag tgattcttca ttatttcatt cttcattgat    180 

tgaattgaac a                                                         191 

 
           
             6  
             346  
             DNA  
             Glycine max  
           
            6 

ttagttcata ctggcttttt tgtttgttca tttgtcattg aaaaaaaatc ttttgttgat     60 

tcaattattt ttatagtgtg tttggaagcc cgtttgagaa aataagaaat cgcatctgga    120 

atgtgaaagt tataactatt tagcttcatc tgtcgttgca agttctttta ttggttaaat    180 

ttttatagcg tgctaggaaa cccattcgag aaaataagaa atcacatctg gaatgtgaaa    240 

gttataactg ttagcttctg agtaaacgtg gaaaaaccac attttggatt tggaaccaaa    300 

ttttatttga taaatgacaa ccaaattgat tttgatggat tttgca                   346 

 
           
             7  
             142  
             DNA  
             Glycine max  
           
            7 

gtatgtgatt aattgcttct cctatagttg ttcttgattc aattacattt tatttatttg     60 

gtaggtccaa gaaaaaaggg aatctttatg cttcctgagg ctgttcttga acatggctct    120 

tttttatgtg tcattatctt ag                                             142 

 
           
             8  
             1228  
             DNA  
             Glycine max  
           
            8 

taacaaaaat aaatagaaaa tagtgggtga acacttaaat gcgagatagt aatacctaaa     60 

aaaagaaaaa aatataggta taataaataa tataactttc aaaataaaaa gaaatcatag    120 

agtctagcgt agtgtttgga gtgaaatgat gttcacctac cattactcaa agattttgtt    180 

gtgtccctta gttcattctt attattttac atatcttact tgaaaagact ttttaattat    240 

tcattgagat cttaaagtga ctgttaaatt aaaataaaaa acaagtttgt taaaacttca    300 

aataaataag agtgaaggga gtgtcatttg tcttctttct tttattgcgt tattaatcac    360 

gtttctcttc tctttttttt ttttcttctc tgctttccac ccattatcaa gttcatgtga    420 

agcagtggcg gatctatgta aatgagtggg gggcaattgc acccacaaga ttttattttt    480 

tatttgtaca ggaataataa aataaaactt tgcccccata aaaaataaat attttttctt    540 

aaaataatgc aaaataaata taagaaataa aaagagaata aattattatt aattttatta    600 

ttttgtactt tttatttagt ttttttagcg gttagatttt tttttcatga cattatgtaa    660 

tcttttaaaa gcatgtaata tttttatttt gtgaaaataa atataaatga tcatattagt    720 

ctcagaatgt ataaactaat aataatttta tcactaaaag aaattctaat ttagtccata    780 

aataagtaaa acaagtgaca attatatttt atatttactt aatgtgaaat aatacttgaa    840 

cattataata aaacttaatg acaggagata ttacatagtg ccataaagat attttaaaaa    900 

ataaaatcat taatacactg tactactata taatattcga tatatatttt taacatgatt    960 

ctcaatagaa aaattgtatt gattatattt tattagacat gaatttacaa gccccgtttt   1020 

tcatttatag ctcttacctg tgatctattg ttttgcttcg ctgtttttgt tggtcaaggg   1080 

acttagatgt cacaatatta atactagaag taaatattta tgaaaacatg taccttacct   1140 

caacaaagaa agtgtggtaa gtggcaacac acgtgttgca tttttggccc agcaataaca   1200 

cgtgtttttg tggtgtacta aaatggac                                      1228 

 
           
             9  
             625  
             DNA  
             Glycine max  
           
            9 

gtacatttta ttgcttattc acctaaaaac aatacaatta gtacatttgt tttatctctt     60 

ggaagttagt cattttcagt tgcatgattc taatgctctc tccattctta aatcatgttt    120 

tcacacccac ttcatttaaa ataagaacgt gggtgttatt ttaatttcta ttcactaaca    180 

tgagaaatta acttatttca agtaataatt ttaaaatatt tttatgctat tattttatta    240 

caaataatta tgtatattaa gtttattgat tttataataa ttatattaaa attatatcga    300 

tattaatttt tgattcactg atagtgtttt atattgttag tactgtgcat ttattttaaa    360 

attggcataa ataatatatg taaccagctc actatactat actgggagct tggtggtgaa    420 

aggggttccc aaccctcctt tctaggtgta catgctttga tacttctggt accttcttat    480 

atcaatataa attatatttt gctgataaaa aaacatggtt aaccattaaa ttcttttttt    540 

aaaaaaaaaa ctgtatctaa actttgtatt attaaaaaga agtctgagat taacaataaa    600 

ctaacactca tttggattca ctgca                                          625 

 
           
             10  
             98  
             DNA  
             Glycine max  
           
            10 

ggtgagtgat tttttgactt ggaagacaac aacacattat tattataata tggttcaaaa     60 

caatgacttt ttctttatga tgtgaactcc atttttta                             98 

 
           
             11  
             115  
             DNA  
             Glycine max  
           
            11 

ggtaactaaa ttactcctac attgttactt tttcctcctt ttttttatta tttcaattct     60 

ccaattggaa atttgaaata gttaccataa ttatgtaatt gtttgatcat gtgca         115 

 
           
             12  
             147  
             DNA  
             Glycine max  
           
            12 

gtaatctcac tctcacactt tctttataca tcgcacacca gtgtgggtta tttgcaacct     60 

acaccgaagt aatgccctat aattaatggg gttaacacat gtccaagtcc aatattttgt    120 

tcacttattt gaacttgaac atgtgta                                        147 

 
           
             13  
             361  
             DNA  
             Glycine max  
           
            13 

gtatcccatt taacacaatt tgtttcatta acattttaag agaatttttt tttcaaaata     60 

gttttcgaaa ttaagcaaat accaagcaaa ttgttagatc tacgcttgta cttgttttaa    120 

agtcaaattc atgaccaaat tgtcctcaca agtccaaacc gtccactatt ttattttcac    180 

ctactttata gcccaatttg tcatttggtt acttcagaaa agagaacccc atttgtagta    240 

aatatattat ttatgaatta tggtagtttc aacataaaac atatttatgt gcagttttgc    300 

catccttcaa aagaagatag aaacttactc catgttactc tgtctatatg taatttcaca    360 

g                                                                    361 

 
           
             14  
             1037  
             DNA  
             Glycine max  
           
            14 

gtaacaaaaa taaatagaaa atagtgagtg aacacttaaa tgttagatac taccttcttc     60 

ttcttttttt tttttttttt gaggttaatg ctagataata gctagaaaga gaaagaaaga    120 

caaatatagg taaaaataaa taatataacc tgggaagaag aaaacataaa aaaagaaata    180 

atagagtcta cgtaatgttt ggatttttga gtgaaatggt gttcacctac cattactcaa    240 

agattctgtt gtctacgtag tgtttggact ttggagtgaa atggtgttca cctaccatta    300 

ctcagattct gttgtgtccc ttagttactg tcttatattc ttagggtata ttctttattt    360 

tacatccttt tcacatctta cttgaaaaga ttttaattat tcattgaaat attaacgtga    420 

cagttaaatt aaaataataa aaaattcgtt aaaacttcaa ataaataaga gtgaaaggat    480 

catcattttt cttctttctt ttattgcgtt attaatcatg cttctcttct tttttttctt    540 

cgctttccac ccatatcaaa ttcatgtgaa gtatgagaaa atcacgattc aatggaaagc    600 

tacaggaacy ttttttgttt tgtttttata atcggaatta atttatactc cattttttca    660 

caataaatgt tacttagtgc cttaaagata atatttgaaa aattaaaaaa attattaata    720 

cactgtacta ctatataata tttgacatat atttaacatg attttctatt gaaaatttgt    780 

atttattatt ttttaatcaa aacccataag gcattaattt acaagaccca tttttcattt    840 

atagctttac ctgtgatcat ttatagcttt aagggactta gatgttacaa tcttaattac    900 

aagtaaatat ttatgaaaaa catgtgtctt accccttaac cttacctcaa caaagaaagt    960 

gtgataagtg gcaacacacg tgttgctttt ttggcccagc aataacacgt gtttttgtgg   1020 

tgtacaaaaa tggacag                                                  1037 

 
           
             15  
             4497  
             DNA  
             Glycine max  
           
            15 

cttgcttggt aacaacgtcg tcaagttatt attttgttct tttttttttt atcatatttc     60 

ttattttgtt ccaagtatgt catattttga tccatcttga caagtagatt gtcatgtagg    120 

aataggaata tcactttaaa ttttaaagca ttgattagtc tgtaggcaat attgtcttct    180 

tcttcctcct tattaatatt ttttattctg ccttcaatca ccagttatgg gagatggatg    240 

taatactaaa taccatagtt gttctgcttg aagtttagtt gtatagttgt tctgcttgaa    300 

gtttagttgt gtgtaatgtt tcagcgttgg cttcccctgt aactgctaca atggtactga    360 

atatatattt tttgcattgt tcattttttt cttttactta atcttcattg ctttgaaatt    420 

aataaaacaa aaagaaggac cgaatagttt gaagtttgaa ctattgccta ttcatgtaac    480 

ttattcaccc aatcttatat agtttttctg gtagagatca ttttaaattg aaggatataa    540 

attaagagga aatacttgta tgtgatgtgt ggcaatttgg aagatcatgc gtagagagtt    600 

taatggcagg ttttgcaaat tgacctgtag tcataattac actgggccct ctcggagttt    660 

tgtgcctttt tgttgtcgct gtgtttggtt ctgcatgtta gcctcacaca gatatttagt    720 

agttgttgtt ctgcatataa gcctcacacg tatactaaac gagtgaacct caaaatcatg    780 

gccttacacc tattgagtga aattaatgaa cagtgcatgt gagtatgtga ctgtgacaca    840 

acccccggtt ttcatattgc aatgtgctac tgtggtgatt aaccttgcta cactgtcgtc    900 

cttgtttgtt tccttatgta tattgatacc ataaattatt actagtatat cattttatat    960 

tgtccatacc attacgtgtt tatagtctct ttatgacatg taattgaatt ttttaattat   1020 

aaaaaataat aaaacttaat tacgtactat aaagagatgc tcttgactag aattgtgatc   1080 

tcctagtttc ctaaccatat actaatattt gcttgtattg atagcccctc cgttcccaag   1140 

agtataaaac tgcatcgaat aatacaagcc actaggcatg gtaaattaaa ttgtgcctgc   1200 

acctcgggat atttcatgtg gggttcatca tatttgttga ggaaaagaaa ctcccgaaat   1260 

tgaattatgc atttatatat cctttttcat ttctagattt cctgaaggct taggtgtagg   1320 

cacctagcta gtagctacaa tatcagcact tctctctatt gataaacaat tggctgtaat   1380 

gccgcagtag aggacgatca caacatttcg tgctggttac tttttgtttt atggtcatga   1440 

tttcactctc tctaatctct ccattcattt tgtagttgtc attatcttta gatttttcac   1500 

tacctggttt aaaattgagg gattgtagtt ctgttggtac atattacaca ttcagcaaaa   1560 

caactgaaac tcaactgaac ttgtttatac tttgacacag ggtctagcaa aggaaacaac   1620 

aatgggaggt agaggtcgtg tggcaaagtg gaagttcaag ggaagaagcc tctctcaagg   1680 

gttccaaaca caaagccacc attcactgtt ggccaactca agaaagcaat tccaccacac   1740 

tgctttcagc gctccctcct cacttcattc tcctatgttg tttatgacct ttcatttgcc   1800 

ttcattttct acattgccac cacctacttc cacctccttc ctcaaccctt ttccctcatt   1860 

gcatggccaa tctattgggt tctccaaggt tgccttctca ctggtgtgtg ggtgattgct   1920 

cacgagtgtg gtcaccatgc cttcagcaag taccaatggg ttgatgatgt tgtgggtttg   1980 

acccttcact caacactttt agtcccttat ttctcatgga aaataagcca tcgccgccat   2040 

cactccaaca caggttccct tgaccgtgat gaagtgtttg tcccaaaacc aaaatccaaa   2100 

gttgcatggt tttccaagta cttaaacaac cctctaggaa gggctgtttc tcttctcgtc   2160 

acactcacaa tagggtggcc tatgtattta gccttcaatg tctctggtag accctatgat   2220 

agttttgcaa gccactacca cccttatgct cccatatatt ctaaccgtga gaggcttctg   2280 

atctatgtct ctgatgttgc tttgttttct gtgacttact ctctctaccg tgttgcaacc   2340 

ctgaaagggt tggtttggct gctatgtgtt tatggggtgc ctttgctcat tgtgaacggt   2400 

tttcttgtga ctatcacata tttgcagcac acacactttg ccttgcctca ttacgattca   2460 

tcagaatggg actggctgaa gggagctttg gcaactatgg acagagatta tgggattctg   2520 

aacaaggtgt ttcatcacat aactgatact catgtggctc accatctctt ctctacaatg   2580 

ccacattacc atgcaatgga ggcaaccaat gcaatcaagc caatattggg tgagtactac   2640 

caatttgatg acacaccatt ttacaaggca ctgtggagag aagcgagaga gtgcctctat   2700 

gtggagccag atgaaggaac atccgagaag ggcgtgtatt ggtacaggaa caagtattga   2760 

tggagcaacc aatgggccat agtgggagtt atggaagttt tgtcatgtat tagtacataa   2820 

ttagtagaat gttataaata agtggatttg ccgcgtaatg actttgtgtg tattgtgaaa   2880 

cagcttgttg cgatcatggt tataatgtaa aaataattct ggtattaatt acatgtggaa   2940 

agtgttctgc ttatagcttt ctgcctaaaa tgcacgctgc acgggacaat atcattggta   3000 

atttttttaa aatctgaatt gaggctactc ataatactat ccataggaca tcaaagacat   3060 

gttgcattga ctttaagcag aggttcatct agaggattac tgcataggct tgaactacaa   3120 

gtaatttaag ggacgagagc aactttagct ctaccacgtc gttttacaag gttattaaaa   3180 

tcaaattgat cttattaaaa ctgaaaattt gtaataaaat gctattgaaa aattaaaata   3240 

tagcaaacac ctaaattgga ctgattttta gattcaaatt taataattaa tctaaattaa   3300 

acttaaattt tataatatat gtcttgtaat atatcaagtt ttttttttta ttattgagtt   3360 

tggaaacata taataaggaa cattagttaa tattgataat ccactaagat cgacttagta   3420 

ttacagtatt tggatgattt gtatgagata ttcaaacttc actcttatca taatagagac   3480 

aaaagttaat actgatggtg gagaaaaaaa aatgttattg ggagcatatg gtaagataag   3540 

acggataaaa atatgctgca gcctggagag ctaatgtatt ttttggtgaa gttttcaagt   3600 

gacaactatt catgatgaga acacaataat attttctact tacctatccc acataaaata   3660 

ctgattttaa taatgatgat aaataatgat taaaatattt gattctttgt taagagaaat   3720 

aaggaaaaca taaatattct catggaaaaa tcagcttgta ggagtagaaa ctttctgatt   3780 

ataattttaa tcaagtttaa ttcattcttt taattttatt attagtacaa aatcattctc   3840 

ttgaatttag agatgtatgt tgtagcttaa tagtaatttt ttatttttat aataaaattc   3900 

aagcagtcaa atttcatcca aataatcgtg ttcgtgggtg taagtcagtt attccttctt   3960 

atcttaatat acacgcaaag gaaaaaataa aaataaaatt cgaggaagcg cagcagcagc   4020 

tgataccacg ttggttgacg aaactgataa aaagcgctgt cattgtgtct ttgtttgatc   4080 

atcttcacaa tcacatctcc agaacacaaa gaagagtgac ccttcttctt gttattccac   4140 

ttgcgttagg tttctacttt cttctctctc tctctctctc tcttcattcc tcatttttcc   4200 

ctcaaacaat caatcaattt tcattcagat tcgtaaattt ctcgattaga tcacggggtt   4260 

aggtctccca ctttatcttt tcccaagcct ttctctttcc ccctttccct gtctgcccca   4320 

taaaattcag gatcggaaac gaactgggtt cttgaatttc actctagatt ttgacaaatt   4380 

cgaagtgtgc atgcactgat gcgacccact cccccttttt tgcattaaac aattatgaat   4440 

tgaggttttt cttgcgatca tcattgcttg aattgaatca tattaggttt agattct      4497 

 
           
             16  
             18  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            16 

atacaagcca ctaggcat                                                   18 

 
           
             17  
             26  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            17 

gattggccat gcaatgaggg aaaagg                                          26 

 
           
             18  
             778  
             DNA  
             Artificial sequence  
             
               misc_feature  
               (1)..(778)  
               unsure at all n locations  
             
           
            18 

atacaagcca ctaggcatgg taaattaaat tgtgcctgca cctcgggata tttcatgtgg     60 

ggttcatcat atttgttgag gaaaagaaac tcccgaaatt gaattatgca tttatatatc    120 

ctttttcatt tctagatttc ctgaaggctt aggtgtaggc acctagctag tagctacaat    180 

atcagcactt ctctctattg ataaacaatt ggctgtaatg ccgcagtaga ggacgatcac    240 

aacatttcgt gctggttact ttttgtttta tggtcatgat ttcactctct ctaatctctc    300 

cattcatttt gtagttgtca ttatctttag atttttcact acctggttta aaattgaggg    360 

attgtagttc tgttggtaca tattacacat tcagcaaaac aactgaaact caactgaact    420 

tgtttatact ttgacacagg gtctagcaaa ggaaacaaca atgggaggta gaggtcgtgt    480 

ggccaaagtg gaagttcaag ggaagaagcc tctctcaagg gttccaaaca caaagccacc    540 

attcactgtt ggccaactca agaaagcaat tccaccacac tgctttcagc gctccctcct    600 

cacttcattc tcctatgttg tttatgacct ttcatttgcc ttcattttct acattgccac    660 

cacctacttc cacctccttc ctcaaccctt ttccctcatt gcatggccaa tcaagccgaa    720 

ttctgcagat atccatcaca tggcggcggn tggngnaggn ntntanaggg cccaattc      778 

 
           
             19  
             2463  
             DNA  
             Glycine max  
           
            19 

actatagggc acgcgtggtc gacggcccgg gctggtcctc ggtgtgactc agccccaagt     60 

gacgccaacc aaacgcgtcc taactaaggt gtagaagaaa cagatagtat ataagtatac    120 

catataagag gagagtgagt ggagaagcac ttctcctttt tttttctctg ttgaaattga    180 

aagtgttttc cgggaaataa ataaaataaa ttaaaatctt acacactcta ggtaggtact    240 

tctaatttaa tccacacttt gactctatat atgttttaaa aataattata atgcgtactt    300 

acttcctcat tatactaaat ttaacatcga tgattttatt ttctgtttct cttctttcca    360 

cctacataca tcccaaaatt tagggtgcaa ttttaagttt attaacacat gtttttagct    420 

gcatgctgcc tttgtgtgtg ctcaccaaat tgcattcttc tctttatatg ttgtatttga    480 

attttcacac catatgtaaa caagattacg tacgtgtcca tgatcaaata caaatgctgt    540 

cttatactgg caatttgata aacagccgtc cattttttct ttttctcttt aactatatat    600 

gctctagaat ctctgaagat tcctctgcca tcgaatttct ttcttggtaa caacgtcgtc    660 

gttatgttat tattttattc tatttttatt ttatcatata tatttcttat tttgttcgaa    720 

gtatgtcata ttttgatcgt gacaattaga ttgtcatgta ggagtaggaa tatcacttta    780 

aaacattgat tagtctgtag gcaatattgt cttctttttc ctcctttatt aatatatttt    840 

gtcgaagttt taccacaagg ttgattcgct ttttttgtcc ctttctcttg ttctttttac    900 

ctcaggtatt ttagtctttc atggattata agatcactga gaagtgtatg catgtaatac    960 

taagcaccat agctgttctg cttgaattta tttgtgtgta aattgtaatg tttcagcgtt   1020 

ggctttccct gtagctgcta caatggtact gtatatctat tttttgcatt gttttcattt   1080 

tttcttttac ttaatcttca ttgctttgaa attaataaaa caatataata tagtttgaac   1140 

tttgaactat tgcctattca tgtaattaac ttattcactg actcttattg tttttctggt   1200 

agaattcatt ttaaattgaa ggataaatta agaggcaata cttgtaaatt gacctgtcat   1260 

aattacacag gaccctgttt tgtgcctttt tgtctctgtc tttggttttg catgttagcc   1320 

tcacacagat atttagtagt tgttctgcat acaagcctca cacgtatact aaaccagtgg   1380 

acctcaaagt catggcctta cacctattgc atgcgagtct gtgacacaac ccctggtttc   1440 

catattgcaa tgtgctacgc cgtcgtcctt gtttgtttcc atatgtatat tgataccatc   1500 

aaattattat atcatttata tggtctggac cattacgtgt actctttatg acatgtaatt   1560 

gagtttttta attaaaaaaa tcaatgaaat ttaactacgt agcatcatat agagataatt   1620 

gactagaaat ttgatgactt attctttcct aatcatattt tcttgtattg atagccccgc   1680 

tgtccctttt aaactcccga gagagtataa aactgcatcg aatattacaa gatgcactct   1740 

tgtcaaatga agggggggaa atgatactac aagccactag gcatggtatg atgctaaatt   1800 

aaattgtgcc tgcaccccag gatatttcat gtgggattca tcatttattg aggaaaactc   1860 

tccaaattga atcgtgcatt tatatttttt ttccatttct agatttcttg aaggcttatg   1920 

gtataggcac ctacaattat cagcacttct ctctattgat aaacaattgg ctgtaatacc   1980 

acagtagaga acgatcacaa cattttgtgc tggttacctt ttgttttatg gtcatgattt   2040 

cactctctct aatctgtcac ttccctccat tcattttgta cttctcatat ttttcacttc   2100 

ctggttgaaa attgtagttc tcttggtaca tactagtatt agacattcag caacaacaac   2160 

tgaactgaac ttctttatac tttgacacag ggtctagcaa aggaaacaat aatgggaggt   2220 

ggaggccgtg tggccaaagt tgaaattcag cagaagaagc ctctctcaag ggttccaaac   2280 

acaaagccac cattcactgt tggccaactc aagaaagcca ttccaccgca ctgctttcag   2340 

cgttccctcc tcacttcatt gtcctatgtt gtttatgacc tttcattggc tttcattttc   2400 

tacattgcca ccacctactt ccacctcctc cctcacccct tttccctcat tgcatggcca   2460 

atc                                                                 2463 

 
           
             20  
             44  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            20 

cuacuacuac uactcgagac aaagccttta gcctttagcc tatg                      44 

 
           
             21  
             36  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            21 

caucaucauc auggatccca tgtctctcta tgcaag                               36 

 
           
             22  
             1704  
             DNA  
             Glycine max  
           
            22 

actatagggc acgcgtggtc gacggcccgg gctggtcctc ggtgtgactc agccccaagt     60 

gacgccaacc aaacgcgtcc taactaaggt gtagaagaaa cagatagtat ataagtatac    120 

catataagag gagagtgagt ggagaagcac ttctcctttt tttttctctg ttgaaattga    180 

aagtgttttc cgggaaataa ataaaataaa ttaaaatctt acacactcta ggtaggtact    240 

tctaatttaa tccacacttt gactctatat atgttttaaa aataattata atgcgtactt    300 

acttcctcat tatactaaat ttaacatcga tgattttatt ttctgtttct cttctttcca    360 

cctacataca tcccaaaatt tagggtgcaa ttttaagttt attaacacat gtttttagct    420 

gcatgctgcc tttgtgtgtg ctcaccaaat tgcattcttc tctttatatg ttgtatttga    480 

attttcacac catatgtaaa caagattacg tacgtgtcca tgatcaaata caaatgctgt    540 

cttatactgg caatttgata aacagccgtc cattttttct ttttctcttt aactatatat    600 

gctctagaat ctctgaagat tcctctgcca tcgaatttct ttcttggtaa caacgtcgtc    660 

gttatgttat tattttattc tatttttatt ttatcatata tatttcttat tttgttcgaa    720 

gtatgtcata ttttgatcgt gacaattaga ttgtcatgta ggagtaggaa tatcacttta    780 

aaacattgat tagtctgtag gcaatattgt cttctttttc ctcctttatt aatatatttt    840 

gtcgaagttt taccacaagg ttgattcgct ttttttgtcc ctttctcttg ttctttttac    900 

ctcaggtatt ttagtctttc atggattata agatcactga gaagtgtatg catgtaatac    960 

taagcaccat agctgttctg cttgaattta tttgtgtgta aattgtaatg tttcagcgtt   1020 

ggctttccct gtagctgcta caatggtact gtatatctat tttttgcatt gttttcattt   1080 

tttcttttac ttaatcttca ttgctttgaa attaataaaa caatataata tagtttgaac   1140 

tttgaactat tgcctattca tgtaattaac ttattcactg actcttattg tttttctggt   1200 

agaattcatt ttaaattgaa ggataaatta agaggcaata cttgtaaatt gacctgtcat   1260 

aattacacag gaccctgttt tgtgcctttt tgtctctgtc tttggttttg catgttagcc   1320 

tcacacagat atttagtagt tgttctgcat acaagcctca cacgtatact aaaccagtgg   1380 

acctcaaagt catggcctta cacctattgc atgcgagtct gtgacacaac ccctggtttc   1440 

catattgcaa tgtgctacgc cgtcgtcctt gtttgtttcc atatgtatat tgataccatc   1500 

aaattattat atcatttata tggtctggac cattacgtgt actctttatg acatgtaatt   1560 

gagtttttta attaaaaaaa tcaatgaaat ttaactacgt agcatcatat agagataatt   1620 

gactagaaat ttgatgactt attctttcct aatcatattt tcttgtattg atagccccgc   1680 

tgtccctttt aaactcccga gaga                                          1704 

 
           
             23  
             4010  
             DNA  
             Glycine max  
           
            23 

acaaagcctt tagcctatgc tgccaataat ggataccaac aaaagggttc ttcttttgat     60 

tttgatccta gcgctcctcc accgtttaag attgcagaaa tcagagcttc aataccaaaa    120 

cattgctggg tcaagaatcc atggagatcc ctcagttatg ttctcaggga tgtgcttgta    180 

attgctgcat tggtggctgc agcaattcac ttcgacaact ggcttctctg gctaatctat    240 

tgccccattc aaggcacaat gttctgggct ctctttgttc ttggacatga ttggtaataa    300 

tttttgtgtt tcttactctt tttttttttt ttttgtttat gatatgaatc tcacacattg    360 

ttctgttatg tcatttcttc ttcatttggc tttagacaac ttaaatttga gatctttatt    420 

atgtttttgc ttatatggta aagtgattct tcattatttc attcttcatt gattgaattg    480 

aacagtggcc atggaagctt ttcagatagc cctttgctga atagcctggt gggacacatc    540 

ttgcattcct caattcttgt gccataccat ggatggttag ttcatactgg cttttttgtt    600 

tgttcatttg tcattgaaaa aaaatctttt gttgattcaa ttatttttat agtgtgtttg    660 

gaagcccgtt tgagaaaata agaaatcgca tctggaatgt gaaagttata actatttagc    720 

ttcatctgtc gttgcaagtt cttttattgg ttaaattttt atagcgtgct aggaaaccca    780 

ttcgagaaaa taagaaatca catctggaat gtgaaagtta taactgttag cttctgagta    840 

aacgtggaaa aaccacattt tggatttgga accaaatttt atttgataaa tgacaaccaa    900 

attgattttg atggattttg caggagaatt agccacagaa ctcaccatga aaaccatgga    960 

cacattgaga aggatgagtc atgggttcca gtatgtgatt aattgcttct cctatagttg   1020 

ttcttgattc aattacattt tatttatttg gtaggtccaa gaaaaaaggg aatctttatg   1080 

cttcctgagg ctgttcttga acatggctct tttttatgtg tcattatctt agttaacaga   1140 

gaagatttac aagaatctag acagcatgac aagactcatt agattcactg tgccatttcc   1200 

atgtttgtgt atccaattta tttggtgagt gattttttga cttggaagac aacaacacat   1260 

tattattata atatggttca aaacaatgac tttttcttta tgatgtgaac tccatttttt   1320 

agttttcaag aagccccgga aaggaaggct ctcacttcaa tccctacagc aatctgtttc   1380 

cacccagtga gagaaaagga atagcaatat caacactgtg ttgggctacc atgttttctc   1440 

tgcttatcta tctctcattc attaactagt ccacttctag tgctcaagct ctatggaatt   1500 

ccatattggg taactaaatt actcctacat tgttactttt tcctcctttt ttttattatt   1560 

tcaattctcc aattggaaat ttgaaatagt taccataatt atgtaattgt ttgatcatgt   1620 

gcagatgttt gttatgtggc tggactttgt cacatacttg catcaccatg gtcaccacca   1680 

gaaactgcct tggtaccgcg gcaaggtaac aaaaataaat agaaaatagt gggtgaacac   1740 

ttaaatgcga gatagtaata cctaaaaaaa gaaaaaaata taggtataat aaataatata   1800 

actttcaaaa taaaaagaaa tcatagagtc tagcgtagtg tttggagtga aatgatgttc   1860 

acctaccatt actcaaagat tttgttgtgt cccttagttc attcttatta ttttacatat   1920 

cttacttgaa aagacttttt aattattcat tgagatctta aagtgactgt taaattaaaa   1980 

taaaaaacaa gtttgttaaa acttcaaata aataagagtg aagggagtgt catttgtctt   2040 

ctttctttta ttgcgttatt aatcacgttt ctcttctctt tttttttttt cttctctgct   2100 

ttccacccat tatcaagttc atgtgaagca gtggcggatc tatgtaaatg agtggggggc   2160 

aattgcaccc acaagatttt attttttatt tgtacaggaa taataaaata aaactttgcc   2220 

cccataaaaa ataaatattt tttcttaaaa taatgcaaaa taaatataag aaataaaaag   2280 

agaataaatt attattaatt ttattatttt gtacttttta tttagttttt ttagcggtta   2340 

gatttttttt tcatgacatt atgtaatctt ttaaaagcat gtaatatttt tattttgtga   2400 

aaataaatat aaatgatcat attagtctca gaatgtataa actaataata attttatcac   2460 

taaaagaaat tctaatttag tccataaata agtaaaacaa gtgacaatta tattttatat   2520 

ttacttaatg tgaaataata cttgaacatt ataataaaac ttaatgacag gagatattac   2580 

atagtgccat aaagatattt taaaaaataa aatcattaat acactgtact actatataat   2640 

attcgatata tatttttaac atgattctca atagaaaaat tgtattgatt atattttatt   2700 

agacatgaat ttacaagccc cgtttttcat ttatagctct tacctgtgat ctattgtttt   2760 

gcttcgctgt ttttgttggt caagggactt agatgtcaca atattaatac tagaagtaaa   2820 

tatttatgaa aacatgtacc ttacctcaac aaagaaagtg tggtaagtgg caacacacgt   2880 

gttgcatttt tggcccagca ataacacgtg tttttgtggt gtactaaaat ggacaggaat   2940 

ggagttattt aagaggtggc ctcaccactg tggatcgtga ctatggttgg atcaataaca   3000 

ttcaccatga cattggcacc catgttatcc accatctttt cccccaaatt cctcattatc   3060 

acctcgttga agcggtacat tttattgctt attcacctaa aaacaataca attagtacat   3120 

ttgttttatc tcttggaagt tagtcatttt cagttgcatg attctaatgc tctctccatt   3180 

cttaaatcat gttttcacac ccacttcatt taaaataaga acgtgggtgt tattttaatt   3240 

tctattcact aacatgagaa attaacttat ttcaagtaat aattttaaaa tatttttatg   3300 

ctattatttt attacaaata attatgtata ttaagtttat tgattttata ataattatat   3360 

taaaattata tcgatattaa tttttgattc actgatagtg ttttatattg ttagtactgt   3420 

gcatttattt taaaattggc ataaataata tatgtaacca gctcactata ctatactggg   3480 

agcttggtgg tgaaaggggt tcccaaccct cctttctagg tgtacatgct ttgatacttc   3540 

tggtaccttc ttatatcaat ataaattata ttttgctgat aaaaaaacat ggttaaccat   3600 

taaattcttt ttttaaaaaa aaaactgtat ctaaactttg tattattaaa aagaagtctg   3660 

agattaacaa taaactaaca ctcatttgga ttcactgcag acacaagcag caaaaccagt   3720 

tcttggagat tactaccgtg agccagaaag atctgcgcca ttaccatttc atctaataaa   3780 

gtatttaatt cagagtatga gacaagacca cttcgtaagt gacactggag atgttgttta   3840 

ttatcagact gattctctgc tcctccactc gcaacgagac tgagtttcaa actttttggg   3900 

ttattattta ttgattctag ctactcaaat tacttttttt ttaatgttat gttttttgga   3960 

gtttaacgtt ttctgaacaa cttgcaaatt acttgcatag agagacatgg              4010 

 
           
             24  
             34  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            24 

acgaattcct cgaggtaaat taaattgtgc ctgc                                 34 

 
           
             25  
             33  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            25 

gcgagatcta tcgatctgtg tcaaagtata aac                                  33 

 
           
             26  
             19  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            26 

catgctttct gtgcttctc                                                  19 

 
           
             27  
             19  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            27 

gttgatccaa ccatagtcg                                                  19 

 
           
             28  
             36  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            28 

gcgatcgatg tatgatgcta aattaaattg tgcctg                               36 

 
           
             29  
             30  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            29 

gcggaattcc tgtgtcaaag tataaagaag                                      30 

 
           
             30  
             30  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            30 

gatcgatgcc cggggtaata atttttgtgt                                      30 

 
           
             31  
             29  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            31 

cacgcctcga gtgttcaatt caatcaatg                                       29 

 
           
             32  
             24  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            32 

cactcgagtt agttcatact ggct                                            24 

 
           
             33  
             25  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            33 

cgcatcgatt gcaaaatcca tcaaa                                           25 

 
           
             34  
             38  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            34 

cuacuacuac uactcgagcg taaatagtgg gtgaacac                             38 

 
           
             35  
             41  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            35 

caucaucauc auctcgagga attcgtccat tttagtacac c                         41 

 
           
             36  
             39  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            36 

cuacuacuac uactcgaggc gcgtacattt tattgctta                            39 

 
           
             37  
             41  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            37 

caucaucauc auctcgagga attctgcagt gaatccaaat g                         41 

 
           
             38  
             22  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            38 

caccatggtc atcatcagaa ac                                              22 

 
           
             39  
             22  
             DNA  
             Artificial sequence  
             
               PCR primer  
             
           
            39 

tcacgatcca cagttgtgag ac                                              22